<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
<journal-id journal-id-type="iso-abbrev">EMBO J</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1460-2075</journal-id>
<journal-id journal-id-type="publisher-id">EMBJ</journal-id>
<journal-id journal-id-type="hwp">embojnl</journal-id>
<journal-title-group>
<journal-title>The EMBO Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0261-4189</issn>
<issn pub-type="epub">1460-2075</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32484994</article-id>
<article-id pub-id-type="pmc">7327499</article-id>
<article-id pub-id-type="doi">10.15252/embj.2019104163</article-id>
<article-id pub-id-type="publisher-id">EMBJ2019104163</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>NR2F1 regulates regional progenitor dynamics in the mouse neocortex and cortical gyrification in BBSOAS patients</article-title>
<alt-title alt-title-type="left-running-head">Michele Bertacchi</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="embj2019104163-cr-0001">
<name>
<surname>Bertacchi</surname>
<given-names>Michele</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-4402-4974</contrib-id>
<xref ref-type="aff" rid="embj2019104163-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0002">
<name>
<surname>Romano</surname>
<given-names>Anna Lisa</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0003">
<name>
<surname>Loubat</surname>
<given-names>Agnès</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0004">
<name>
<surname>Tran Mau‐Them</surname>
<given-names>Frederic</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0005">
<name>
<surname>Willems</surname>
<given-names>Marjolaine</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0006">
<name>
<surname>Faivre</surname>
<given-names>Laurence</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0007">
<name>
<surname>Khau van Kien</surname>
<given-names>Philippe</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0008">
<name>
<surname>Perrin</surname>
<given-names>Laurence</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0009">
<name>
<surname>Devillard</surname>
<given-names>Françoise</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0010">
<name>
<surname>Sorlin</surname>
<given-names>Arthur</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0006">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0011">
<name>
<surname>Kuentz</surname>
<given-names>Paul</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-2814-6303</contrib-id>
<xref ref-type="aff" rid="embj2019104163-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0012">
<name>
<surname>Philippe</surname>
<given-names>Christophe</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0013">
<name>
<surname>Garde</surname>
<given-names>Aurore</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0014">
<name>
<surname>Neri</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0012">
<sup>12</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0013">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0015">
<name>
<surname>Di Giaimo</surname>
<given-names>Rossella</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-3604-3697</contrib-id>
<xref ref-type="aff" rid="embj2019104163-aff-0014">
<sup>14</sup>
</xref>
<xref ref-type="aff" rid="embj2019104163-aff-0015">
<sup>15</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0016">
<name>
<surname>Oliviero</surname>
<given-names>Salvatore</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0012">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0017">
<name>
<surname>Cappello</surname>
<given-names>Silvia</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-4539-9038</contrib-id>
<xref ref-type="aff" rid="embj2019104163-aff-0015">
<sup>15</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0018">
<name>
<surname>D'Incerti</surname>
<given-names>Ludovico</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0016">
<sup>16</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="embj2019104163-cr-0019">
<name>
<surname>Frassoni</surname>
<given-names>Carolina</given-names>
</name>
<xref ref-type="aff" rid="embj2019104163-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="embj2019104163-cr-0020">
<name>
<surname>Studer</surname>
<given-names>Michèle</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-7105-2957</contrib-id>
<xref ref-type="aff" rid="embj2019104163-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>michele.studer@unice.fr</email>
</address>
</contrib>
</contrib-group>
<aff id="embj2019104163-aff-0001">
<label><sup>1</sup></label>
<institution>Université Côte d'Azur, CNRS, Inserm, iBV</institution>
<city>Paris</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Clinical and Experimental Epileptology Unit</named-content>
<institution>Fondazione IRCCS Istituto Neurologico Carlo Besta</institution>
<city>Milano</city>
<country country="IT">Italy</country>
</aff>
<aff id="embj2019104163-aff-0003">
<label><sup>3</sup></label>
<institution>UMR1231 GAD, Inserm ‐ Université Bourgogne‐Franche Comté</institution>
<city>Dijon</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares</named-content>
<institution>FHU‐TRANSLAD, CHU Dijon Bourgogne</institution>
<city>Dijon</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Hôpital Arnaud de Villeneuve, Service de Génétique Médicale</named-content>
<institution>CHU de Montpellier</institution>
<city>Montpellier</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Centre de Référence maladies rares « Anomalies du développement et syndromes malformatifs »</named-content>
<named-content content-type="organisation-division">Centre de Génétique, FHU‐TRANSLAD</named-content>
<institution>CHU Dijon Bourgogne</institution>
<city>Dijon</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Hôpital Carémeau</named-content>
<named-content content-type="organisation-division">UF de Génétique Médicale et Cytogénétique</named-content>
<named-content content-type="organisation-division">Centre de Compétences Anomalies du Développement et Syndromes Malformatifs</named-content>
<institution>CHU de Nîmes</institution>
<city>Nîmes</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Unité Fonctionnelle de Génétique Clinique</named-content>
<institution>Hôpital Robert Debré</institution>
<city>Paris</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Département de Génétique et Procréation</named-content>
<named-content content-type="organisation-division">Hôpital Couple‐Enfant</named-content>
<institution>CHU de Grenoble</institution>
<city>Grenoble</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Centre de référence maladies rares « Déficiences intellectuelles de causes rares »</named-content>
<named-content content-type="organisation-division">Centre de Génétique, FHU‐TRANSLAD</named-content>
<institution>CHU Dijon Bourgogne</institution>
<city>Dijon</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0011">
<label><sup>11</sup></label>
<institution>Génétique Biologique, PCBio, Centre Hospitalier Universitaire de Besançon</institution>
<city>Besançon</city>
<country country="FR">France</country>
</aff>
<aff id="embj2019104163-aff-0012">
<label><sup>12</sup></label>
<named-content content-type="organisation-division">Epigenetics Unit</named-content>
<named-content content-type="organisation-division">Italian Institute for Genomic Medicine</named-content>
<institution>University of Torino</institution>
<city>Torino</city>
<country country="IT">Italy</country>
</aff>
<aff id="embj2019104163-aff-0013">
<label><sup>13</sup></label>
<named-content content-type="organisation-division">Leibniz Institute on Aging</named-content>
<institution>Fritz Lipmann Institute (FLI)</institution>
<city>Jena</city>
<country country="DE">Germany</country>
</aff>
<aff id="embj2019104163-aff-0014">
<label><sup>14</sup></label>
<named-content content-type="organisation-division">Department of Biology</named-content>
<institution>University of Naples Federico II</institution>
<city>Napoli</city>
<country country="IT">Italy</country>
</aff>
<aff id="embj2019104163-aff-0015">
<label><sup>15</sup></label>
<institution>Max Planck Institute of Psychiatry</institution>
<city>München</city>
<country country="DE">Germany</country>
</aff>
<aff id="embj2019104163-aff-0016">
<label><sup>16</sup></label>
<named-content content-type="organisation-division">Neuroradiology Unit</named-content>
<institution>Fondazione IRCCS Istituto Neurologico Carlo Besta</institution>
<city>Milano</city>
<country country="IT">Italy</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +33 489150720; E‐mail: <email>michele.studer@unice.fr</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>39</volume>
<issue>13</issue>
<issue-id pub-id-type="doi">10.1002/embj.v39.13</issue-id>
<elocation-id>e104163</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>12</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>4</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 EMBO <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2020 The Authors. Published under the terms of the CC BY 4.0 license</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EMBJ-39-e104163.pdf"></self-uri>
<abstract id="embj2019104163-abs-0001">
<title>Abstract</title>
<p>The relationships between impaired cortical development and consequent malformations in neurodevelopmental disorders, as well as the genes implicated in these processes, are not fully elucidated to date. In this study, we report six novel cases of patients affected by BBSOAS (Boonstra‐Bosch‐Schaff optic atrophy syndrome), a newly emerging rare neurodevelopmental disorder, caused by loss‐of‐function mutations of the transcriptional regulator <italic>NR2F1</italic>. Young patients with <italic>NR2F1</italic> haploinsufficiency display mild to moderate intellectual disability and show reproducible polymicrogyria‐like brain malformations in the parietal and occipital cortex. Using a recently established BBSOAS mouse model, we found that <italic>Nr2f1</italic> regionally controls long‐term self‐renewal of neural progenitor cells via modulation of cell cycle genes and key cortical development master genes, such as <italic>Pax6</italic>. In the human fetal cortex, distinct NR2F1 expression levels encompass gyri and sulci and correlate with local degrees of neurogenic activity. In addition, reduced NR2F1 levels in cerebral organoids affect neurogenesis and PAX6 expression. We propose <italic>NR2F1</italic> as an area‐specific regulator of mouse and human brain morphology and a novel causative gene of abnormal gyrification.</p>
</abstract>
<abstract abstract-type="graphical" id="embj2019104163-abs-0003">
<p>Reduced levels of the neuronal differentiation factor NR2F1/COUP‐TFI impairs brain cortex folding in humans, and disrupts regional neural progenitor dynamics in the neocortex of a BBSOAS disease mouse model.<boxed-text content-type="graphic" id="embj2019104163-blkfxd-0002" orientation="portrait" position="anchor"><graphic id="nlm-graphic-3" orientation="portrait" position="anchor" xlink:href="EMBJ-39-e104163-g015.jpg"></graphic></boxed-text>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="embj2019104163-kwd-0001">BBSOAS</kwd>
<kwd id="embj2019104163-kwd-0002">cell cycle dynamics</kwd>
<kwd id="embj2019104163-kwd-0003">cortical folding</kwd>
<kwd id="embj2019104163-kwd-0004">neurodevelopmental disease</kwd>
<kwd id="embj2019104163-kwd-0005">
<italic>NR2F1/COUP‐TFI</italic>
</kwd>
</kwd-group>
<kwd-group kwd-group-type="subject-categories">
<title>Subject Categories</title>
<kwd>Development &amp; Differentiation</kwd>
<kwd>Neuroscience</kwd>
<kwd>Regenerative Medicine</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>
<institution-wrap>
<institution>Agence Nationale de la Recherche (ANR) </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100001665</institution-id>
</institution-wrap>
</funding-source>
<award-id>ANR‐15‐NEUR‐0002‐04</award-id>
<award-id>ANR‐11‐LABX‐0028‐01</award-id>
</award-group>
<award-group id="funding-0002">
<funding-source>
<institution-wrap>
<institution>European Molecular Biology Organization (EMBO) </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100004410</institution-id>
</institution-wrap>
</funding-source>
<award-id>STF#8035</award-id>
</award-group>
<award-group id="funding-0003">
<funding-source>Ville de Nice ‐ Aides Individuelles aux Jeunes Chercheurs</funding-source>
</award-group>
<award-group id="funding-0004">
<funding-source>
<institution-wrap>
<institution>Fondation Jérôme Lejeune </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100007353</institution-id>
</institution-wrap>
</funding-source>
<award-id>199162</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="13"></fig-count>
<table-count count="1"></table-count>
<page-count count="25"></page-count>
<word-count count="20157"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>01 July 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.5 mode:remove_FC converted:01.07.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="embj2019104163-cit-1001" publication-type="journal">
<source xml:lang="en"/>EMBO Journal (<year>2020</year>) <volume>39</volume>: <elocation-id>e104163</elocation-id>
</mixed-citation>
</p>
</notes>
</front>
<body id="embj2019104163-body-0001">
<sec id="embj2019104163-sec-0001">
<title>Introduction</title>
<p>During development, neural progenitor (NP) cells shape the cerebral cortex by means of a delicate balance between neurogenesis (differentiation) and progenitor maintenance (self‐renewal) (Florio &amp; Huttner, <xref ref-type="ref" rid="embj2019104163-bib-0047">2014</xref>). Different NP subtypes concur to produce neurons in a direct or indirect (via intermediate progenitor—IP) way; differentiating neurons migrate to the cortical plate (CP), where they settle down to mature into distinct neuronal subtypes radially organized into layers and circuits (Dehay &amp; Kennedy, <xref ref-type="ref" rid="embj2019104163-bib-0040">2007</xref>; Kumamoto &amp; Hanashima, <xref ref-type="ref" rid="embj2019104163-bib-0069">2014</xref>). However, layers are not homogenously distributed along the antero‐posterior (A‐P) and latero‐medial (L‐M) axes of the developing neocortex, generating histological discontinuities and cytoarchitecturally defined regions, which will differentiate into functional areas (Alfano &amp; Studer, <xref ref-type="ref" rid="embj2019104163-bib-0002">2013</xref>). Although it is well accepted that presumptive areas, called proto‐areas, get specified during early development (Cadwell <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0030">2019</xref>), the underlying molecular and cellular mechanisms are still not fully elucidated. In particular, it is not well known whether abnormal area‐specific development in humans can lead to particular brain malformations.</p>
<p>Malformations of cortical development (MCDs) represent a heterogenous group of neurodevelopmental diseases in which structural brain anomalies are associated with complex neurodevelopmental disorders (Juric‐Sekhar &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0062">2019</xref>). They can be classified on the basis of their etiology: impairments in NP proliferation, neurogenesis, neuron migration, differentiation, apoptosis, and/or cortical organization (Manzini &amp; Walsh, <xref ref-type="ref" rid="embj2019104163-bib-0079">2011</xref>; Barkovich <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0011">2012</xref>). While disorders of reduced proliferation result mainly in microcephaly, altered cell migration can lead either to various types of cellular heterotopia, in which differentiating neurons fail to reach their correct destination and form aggregates in ectopic positions, or to a thick disorganized CP often leading to lissencephaly (Parrini <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0093">2016</xref>). Finally, affected NP physiology and cell migration have also been hypothesized to cause abnormal gyrification, such as polymicrogyria (PMG), a heterogenous group of malformations characterized by abnormal shape and number of cortical gyri (Barkovich <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0011">2012</xref>; Sun &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0107">2014</xref>; Parrini <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0093">2016</xref>). Gyral abnormalities are often associated with mild to moderate intellectual disability (ID), infantile spasms, and impaired oromotor skills (Jansen, <xref ref-type="ref" rid="embj2019104163-bib-0059">2005</xref>; Parrini <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0093">2016</xref>). Despite some genetic abnormalities underlying MCDs, particularly related to cell migration, are starting to be elucidated (Cappello <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0032">2013</xref>; Juric‐Sekhar &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0062">2019</xref>; Uzquiano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0115">2019</xref>), the cellular and molecular mechanisms underlying abnormal gyrification are still not well understood.</p>
<p>The transcriptional regulator Nr2f1 (Nuclear Receptors Nomenclature, 1999), also known as COUP‐TFI, is an orphan nuclear receptor belonging to the superfamily of the steroid/thyroid hormone receptors (Qiu <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0096">1994</xref>; Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0016">2018</xref>). Expressed along the neocortex following a high‐posterior to low‐anterior gradient in progenitors and post‐mitotic neurons, Nr2f1 plays several key roles during areal organization (Zhou <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0124">2001</xref>; Armentano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0009">2007</xref>; Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0016">2018</xref>) and controls both neurogenesis (Faedo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0043">2008</xref>) and neuronal cell migration in embryonic (Alfano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0001">2011</xref>; Lodato <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0076">2011</xref>; Parisot <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0091">2017</xref>) and adult stages (Bovetti <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0026">2013</xref>; Flore <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0046">2016</xref>; Bonzano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0022">2018</xref>). Although Nr2f1 has been extensively studied in post‐mitotic sensory area identity acquisition (Alfano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0003">2014</xref>), its ultimate function in NP physiology during early corticogenesis, when cell proliferation needs to be tightly controlled, is poorly understood.</p>
<p>Recent reports show that <italic>Nr2f1</italic> and <italic>NR2F1</italic> follows a similar graded expression profile in the mouse and human brains, respectively (Alzu'bi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0005">2017a</xref>,<xref ref-type="ref" rid="embj2019104163-bib-0006">b</xref>; Yang <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0121">2017</xref>), in accordance with its evolutionary highly conserved sequence and protein homology (Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0016">2018</xref>). In the last few years, deletion and point mutations in the <italic>NR2F1</italic> locus have been identified in patients with optic nerve atrophy associated with developmental delay, autistic features, epilepsy, and ID (Brown <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0028">2009</xref>; Cardoso <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0034">2009</xref>; Al‐Kateb <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0004">2013</xref>; Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>, <xref ref-type="ref" rid="embj2019104163-bib-0037">2017</xref>; Kaiwar <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0063">2017</xref>; Martín‐Hernández <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0081">2018</xref>). At present, patients with <italic>NR2F1</italic> haploinsufficiency are diagnosed for the Bosch‐Boonstra‐Schaaf optic atrophy syndrome (BBSOAS), an emerging neurodevelopmental autosomal dominant disorder (OMIM #615722; ORPHANET #401777) leading to a broad range of clinical phenotypes associated with visual and cognitive deficits reviewed in Bertacchi <italic>et al</italic> (<xref ref-type="ref" rid="embj2019104163-bib-0016">2018</xref>). Given the high prevalence (almost 70%) of visual deficits in BBSOAS patients (Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0016">2018</xref>), previous studies have mainly focused on elucidating the chiasm and optic nerve atrophy of young children. This, together with the difficulty of obtaining high‐resolution magnetic resonance imaging (MRI) at young age, has limited the investigation of possible brain malformations, which could correlate with the high frequency of ID (more than 80%) and epileptic seizures (40%) in BBSOAS patients. New reports are constantly expanding the BBSOAS clinical spectrum (Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>; Martín‐Hernández <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0081">2018</xref>; Bojanek <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0020">2019</xref>; Park <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0092">2019</xref>; Rech <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0501">2020</xref>), as more patients are identified and the pathophysiology of different brain regions or different organs starts to be explored.</p>
<p>In this study, we describe for the first time abnormal folding in six new patients with <italic>de novo</italic> point variants within the start codon for translation, the DNA‐binding Domain (DBD) or the ligand‐binding domain (LBD) of NR2F1. All these patients show ID features, behavioral disorders, and delayed motor and language development, besides optic atrophy. Interestingly, five out of six patients have a unilateral PMG‐like pattern along the parieto‐occipital cortical region, and two patients show abnormally elongated occipital convolutions. To understand the mechanisms at the basis of this regionalized morphological impairment, we used the mouse <italic>Nr2f1</italic> loss‐of‐function model, recently established to represent a reliable animal model for BBSOA syndrome (Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0017">2019</xref>). We particularly focused on NP physiology and showed that Nr2f1 finely controls the balance between self‐renewal of distinct progenitor cell types and differentiation of specific neuronal classes in the occipital cortex. Notably, we observed cell cycle shortening and abnormally increased proliferative cell divisions in the mutant embryo, resulting in an early expansion of the NP pool. At the molecular level, we found that Nr2f1/NR2F1 influences NP physiology in mouse cortex and human organoids by modulating PAX6, a known patterning gene controlling progenitor expansion, as well as the cell cycle inhibitor P21 in the mouse cortex. Finally, we show that genetic manipulation of Pax6 levels rescues self‐renewal features of <italic>Nr2f1</italic>‐deficient NPs. Together, our data demonstrate that Nr2f1 operates a regional control of NP physiology, linking local progenitor activity to positional identity along neocortical axes. This can have direct consequences on brain morphology, as distinct cortical regions are abnormally developed in BBSOAS patients and in the mouse model. We propose that Nr2f1/NR2F1 orchestrates cortical size and folding in an area‐specific manner by fine‐tuning cell cycle progression and local production of specific progenitor subtypes. Finally, we suggest aberrant local gyrification and cortical malformations as novel morphological features expanding the BBSOAS clinical phenotype.</p>
</sec>
<sec id="embj2019104163-sec-0002">
<title>Results</title>
<sec id="embj2019104163-sec-0003">
<title>
<italic>NR2F1</italic> loss‐of‐function variants cause cortical malformations and abnormal gyrification in BBSOAS patients</title>
<p>To understand the etiology of cortical malformations in human patients and their correlation with ID, we ascertained a collection of seventeen novel cases of patients (M. Bertacchi and M. Studer, unpublished) with BBSOA syndrome. Previously published high‐resolution MRI scans have mainly focused on the optic nerve/optic chiasm hypotrophy (Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>), resulting in poor characterization of possible brain malformations due to <italic>NR2F1</italic> pathogenic variants, despite the high frequency of these patients in being diagnosed with ID. In this study, we report MRI brain scans of six novel patients carrying <italic>de novo NR2F1</italic> variants localized along the whole gene sequence and characterized by developmental delay, behavioral disorders, speech difficulties, and autistic‐like traits (Table <xref ref-type="table" rid="embj2019104163-tbl-0001">1</xref>; Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>A–G). Analysis from the MRI data revealed a thinning of the corpus callosum and optic nerve chiasm together with optic nerve hypotrophy (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>A–F), key diagnostic morphological features of BBSOAS patients (Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>). Interestingly, careful analysis of axial images revealed subtle cortical malformations in five patients, such as altered patterns of gyrification, resembling PMG, at the level of the supramarginal and angular convolutions of the inferior parietal cortex (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>B–F). This microgyria‐like abnormality was found only and always on the left side (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>B–F). MRI data also disclosed an elongation of the right superior occipital gyrus without evident gyrification defects in patient (P) 1 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>A) and abnormally prominent occipital convolutions in P2 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>B).</p>
<table-wrap id="embj2019104163-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Novel NR2F1 variants and phenotypic features of patients with BBSOA syndrome</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient ID</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gender/Age at MRI evaluation</th>
<th align="left" colspan="1" rowspan="1" valign="top">Genetics</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<italic>In Silico</italic>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Clinical features: general</th>
<th align="left" colspan="1" rowspan="1" valign="top">Neurological exam: cognitive level</th>
<th align="left" colspan="1" rowspan="1" valign="top">Ophthalmologic disorders</th>
<th align="left" colspan="1" rowspan="1" valign="top">Brain MRI: general</th>
<th align="left" colspan="1" rowspan="1" valign="top">Brain MRI: morphological malformations</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">P1</td>
<td align="left" colspan="1" rowspan="1">Female, 1 year 4 months</td>
<td align="left" colspan="1" rowspan="1">chr5:g.92921154G&gt;A; NM_005654.4:c.425G&gt;A; <italic>p</italic>.Arg142His; <italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">GnomAD: 0 CADD: 33 Polyphen‐2: 1 GERP: 3.7</td>
<td align="left" colspan="1" rowspan="1">Developmental delay, behavioral disorders, hypotonia, speech difficulties, stereotype movements, infantile spasms</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability, autistic‐like traits, hyperactive behavior</td>
<td align="left" colspan="1" rowspan="1">Amblyopia; optic atrophy</td>
<td align="left" colspan="1" rowspan="1">Thinning of the corpus callosum; hypoplasia of optic nerves and optic chiasm;</td>
<td align="left" colspan="1" rowspan="1">Abnormally elongated occipital convolutions (right side)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P2</td>
<td align="left" colspan="1" rowspan="1">Male, 3 years 7 months</td>
<td align="left" colspan="1" rowspan="1">chr5:g.92923888_92923889 delinsCT; NM_005654.4:c.729_730delinsCT; p.Gln244*; <italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">GnomAD: 0 CADD: 50 Polyphen‐2: ND GERP: 4.5</td>
<td align="left" colspan="1" rowspan="1">Developmental delay, behavioral disorders, hypotonia, bilateral inguinal hernias</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability, fine motor and praxis disorders</td>
<td align="left" colspan="1" rowspan="1">Hypermetropia, strabismus</td>
<td align="left" colspan="1" rowspan="1">Thinning of the posterior half of the corpus callosum; ventricular asymmetry, and mild ventricular enlargement</td>
<td align="left" colspan="1" rowspan="1">Abnormal gyral pattern of the occipital cortex at the supramarginal and angular gyri (left side)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P3</td>
<td align="left" colspan="1" rowspan="1">Female, 5 years 10 months</td>
<td align="left" colspan="1" rowspan="1">chr5 g.92920844G&gt;T; NM_005654.4: c.115G&gt;T; p.Glu39*; <italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">GnomAD: 0 CADD: 36 Polyphen‐2: ND GERP: ND</td>
<td align="left" colspan="1" rowspan="1">Developmental delay, behavioral disorders, hypotonia, speech difficulties, epileptic seizures, precocious puberty</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability, stereotypical movements, attention deficits</td>
<td align="left" colspan="1" rowspan="1">Strabismus, low visual acuity, severe bilateral optic atrophy</td>
<td align="left" colspan="1" rowspan="1">Thinning of the corpus callosum and optic chiasm, superior cerebellar vermis atrophy, ectopic nodular heterotopy</td>
<td align="left" colspan="1" rowspan="1">Abnormal gyral pattern of posterior temporal, supramarginal and angular gyri (left side)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P4</td>
<td align="left" colspan="1" rowspan="1">Female, 3 years 5 months</td>
<td align="left" colspan="1" rowspan="1">chr5:g.92920731T&gt;C; NM_005654.4:c.2T&gt;C; p.? <italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">GnomAD: 0 CADD: 22 Polyphen‐2: 0.02 GERP: 2.3</td>
<td align="left" colspan="1" rowspan="1">Developmental delay, behavioral disorders, speech difficulties</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability, autistic‐like traits, hyperactive behavior</td>
<td align="left" colspan="1" rowspan="1">Thinning of the optic chiasm</td>
<td align="left" colspan="1" rowspan="1">Thinning of the posterior half of the corpus callosum; small asymmetry of the occipital cortex</td>
<td align="left" colspan="1" rowspan="1">Abnormal gyral pattern of the cortex of the supramarginal and angular gyri (left side)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P5</td>
<td align="left" colspan="1" rowspan="1">Female, 6 years 7 months</td>
<td align="left" colspan="1" rowspan="1">chr5:g.92921021T&gt;C; NM_005654.4:c.292T&gt;C; p.Tyr98His; <italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">GnomAD: 0</td>
<td align="left" colspan="1" rowspan="1">Developmental delay, behavioral disorders, hypotonia, stereotypical movements</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability, autistic‐like traits</td>
<td align="left" colspan="1" rowspan="1">Optic nerve atrophy, strabismus, hypermetropia, nystagmus</td>
<td align="left" colspan="1" rowspan="1">Thinning of the posterior half of the corpus callosum, hypoplasia of the optic chiasm</td>
<td align="left" colspan="1" rowspan="1">Abnormal gyral pattern of the cortex of the supramarginal and angular gyri (left side)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P6</td>
<td align="left" colspan="1" rowspan="1">Male, 12 years 2 months</td>
<td align="left" colspan="1" rowspan="1">chr5:g.92924126_92924127delAA NM_005654.4:c.967_968delAA p.Lys323Serfs*73 <italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">GnomAD: 0</td>
<td align="left" colspan="1" rowspan="1">Delayed motor development, speech difficulties, pectus excavatum, pes planus, scoliosis, triangular face, thin upper lip, anteverted nares, high palate, gastroesophageal reflux, severe apnea</td>
<td align="left" colspan="1" rowspan="1">Intellectual disability, autistic‐like traits</td>
<td align="left" colspan="1" rowspan="1">Optic nerve atrophy, strabismus, hypermetropia, low visual acuity, tubular vision</td>
<td align="left" colspan="1" rowspan="1">Short corpus callosum (&lt;3<sup>rd</sup> percentile), thin optic nerves and chiasm, hypoplastic olfactory lobes</td>
<td align="left" colspan="1" rowspan="1">Abnormal gyral pattern of the cortex of the supramarginal and angular gyri (left side)</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<fig fig-type="Figure" id="embj2019104163-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<title>Cortical malformations in BBSOAS patients with NR2F1 haploinsufficiency</title>
<p>
<list id="embj2019104163-list-0002" list-type="simple"><list-item><label>A–F</label><p>Cortical malformations observed in six novel BBSOAS patients (See Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>A–F for additional MRI panel and Table <xref ref-type="table" rid="embj2019104163-tbl-0001">1</xref> for clinical features). Patient (P)1 shows abnormally elongated occipital convolutions (arrowheads in A), whereas abnormal gyrification of supramarginal and angular gyri is present in five out of six individuals (P2‐P6; B‐F). B′, C′, and C″ highlight the abnormally convoluted regions boxed in (B and C).</p></list-item><list-item><label>G</label><p>Schematic representation of the human NR2F1 protein sequence (based on the current annotation: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/NP_005645.1">https://www.ncbi.nlm.nih.gov/protein/NP_005645.1</ext-link>), showing novel variants of a new BBSOAS patient cohort. Key amino acids for the functioning of the DNA‐binding domain (DBD) or the ligand‐binding domain (LBD) are listed in boxes.</p></list-item><list-item><label>H, H′</label><p>TBR2 (green in H), SOX2 (red in H), and NR2F1 (yellow in H′) immunofluorescence (IF) of a GW11 section of human neocortex (see also Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>G–G‴).</p></list-item><list-item><label>I</label><p>NR2F1 expression (quantified by pixel intensity) at different L‐M levels (see also Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>G–G‴) and in different regions along the A‐P extent of the cortex, as indicated. <italic>n</italic> ≥ 3 sections from <italic>n</italic> = 1 fetal brain.</p></list-item><list-item><label>J–L′</label><p>NR2F1 (red) IF of human GW14 neocortex, showing expression levels in the CP (K, L) and VZ (K′, L′) around primary convolutions in the posterior‐most cortex (see also Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>H). High NR2F1 is detected in the progenitor area of a gyrus (L′).</p></list-item><list-item><label>M, M′</label><p>NR2F1 level as measured on single cells in the VZ (M) and CP (M′) of sulci and gyri, as in (J‐L′). <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 1 fetal brain.</p></list-item><list-item><label>N, O</label><p>NR2F1 (red) and TBR2 (green) immunostaining of the same regions shown in (J‐L′). NR2F1 level as measured in single TBR2<sup>+</sup> IPs by pixel intensity is shown in graph (O). <italic>n</italic> ≥ 4 convolutions from <italic>n</italic> = 1 fetal brain (<italic>n</italic> = 2 sections).</p></list-item><list-item><label>P–R</label><p>NR2F1 (red) and HOPX (green) immunostaining of the same regions shown in (J‐L′) (see also Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>H). Virtually, all HOPX<sup>+</sup> bRGs are also NR2F1<sup>+</sup> (magnification in P″) and their number is greatly increased in gyri (P″) compared to sulci (P′), as quantified in (R). At a single cell level, NR2F1 pixel intensity is higher in oSVZ HOPX<sup>+</sup> cells in gyri compared to sulci (Q). <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 1 fetal brain.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. In (I, R), the number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the cortex. In graphs, data are represented as means ± SEM. Two‐way ANOVA (I) and Student′s <italic>t</italic>‐test (M, M′, O, Q, R) (*<italic>P</italic> &lt; 0.05, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. CP: cortical plate; iSVZ: inner subventricular zone; IZ: intermediate zone; oSVZ: outer subventricular zone; SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="EMBJ-39-e104163-g002"></graphic>
</fig>
<fig fig-type="Figure" id="embj2019104163-fig-0001ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV1</label>
<caption>
<title>MRI features of six novel BBSOAS patients and NR2F1 expression along the L‐M and A‐P axes</title>
<p>
<list id="embj2019104163-list-0010" list-type="simple"><list-item><label>A</label><p>Two‐year‐old female patient with thinning of the optic chiasm (left image) and optic nerves (right image).</p></list-item><list-item><label>B</label><p>Four‐year‐old male patient showing prominent occipital convolutions (left) together with thinning of the posterior half of corpus callosum (right).</p></list-item><list-item><label>C</label><p>Six‐year‐old female patient with thinning of the posterior half of corpus callosum (left) and of the optic chiasm (right).</p></list-item><list-item><label>D</label><p>Three‐year‐old female patient with small asymmetry of the occipital cortex (left), thinning of the posterior half of corpus callosum (right), and normal thickness of optic nerves (not shown).</p></list-item><list-item><label>E</label><p>Seven‐year‐old female patient with thinning of the optic chiasm (left) and mild thinning of posterior corpus callosum (right).</p></list-item><list-item><label>F</label><p>Twelve‐year‐old male patient showing mild thinning of the optic nerves (left) and of the posterior half of corpus callosum (right).</p></list-item><list-item><label>G–G‴</label><p>Low‐magnification DAPI staining and schematic representation of a GW11 coronal section (G) displaying the position of high‐magnification views in (G′‐G‴) and in Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>H and H′. Colors in (G) display lateral, dorsal, and medial areas taken for NR2F1 pixel intensity measurements at GW11 (see Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>I). Representative images of NR2F1 (red) immunofluorescence (IF) at different levels along the latero‐medial (L‐M) extent of the cortex, as shown in (G′‐G″).</p></list-item><list-item><label>H</label><p>Low‐magnification DAPI staining of a GW14 sagittal section displaying the position of high‐magnification images showed in (I‐I″, K‐K″) and in Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>J–L′, N, N′ and P–P″.</p></list-item><list-item><label>I, J</label><p>NR2F1 (red) IF at GW14 depicting increasing expression levels in the posterior‐most cortex (I″), as quantified in (J). <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 1 fetal brain.</p></list-item><list-item><label>K–L″</label><p>TBR2 (green) and SOX2 (red) IF of a GW14 primary convolution (detail taken from H). The average number of different NP classes in the fissure (K′) and convoluted region (K″) is quantified in (L‐L″). The convoluted region is populated by a higher number of both apical and basal progenitors. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 1 fetal brain.</p></list-item><list-item><label>M</label><p>Schematic representation of human NR2F1 expression levels correlated with distinct cytoarchitectures along cortical convolutions. Expression of NR2F1 displays local modules of low versus medium/high expression levels in sulci and gyri, respectively. Medium/high NR2F1 expression in gyri is associated with high basal RG numbers and high neurogenic activity promoting radial and tangential expansion, whereas low expression is correlated with a small progenitor pool and low neurogenic potential.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. In (J, L‐L″), the number of positive cells or the pixel intensity was quantified in 100 μm‐width boxes, randomly placed across the cortex in exemplificative regions, as shown in (H). Data are represented as means ± SEM. Two‐way ANOVA (J) and Student′s <italic>t</italic>‐test (L‐L″) (**P &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. In (A‐F), arrowheads highlight the morphological features described above the MRI for each patient. CP: cortical plate; IZ: intermediate zone; iSVZ/oSVZ: inner/outer subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="EMBJ-39-e104163-g003"></graphic>
</fig>
<p>Genomic DNA samples from all patients were subjected to exome sequencing (ES), as previously described (Orphanomix Physicians’ Group <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0090">2018</xref>). Genome Aggregation Database (GnomAD) metrics (misZ: 4.17; pLI: 0.99) predict the <italic>NR2F1</italic> gene to be highly intolerant to missense mutations, in agreement with the pathogenic phenotype caused by loss‐of‐function (LOF) variants (Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>). We identified six novel mutations in the <italic>NR2F1</italic> gene (Table <xref ref-type="table" rid="embj2019104163-tbl-0001">1</xref>; Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>G), absent from the GnomAD database. In P1, a missense variant (c.425G&gt;A; p.Arg142His) was detected in the functional C4‐type zinc‐finger domain of the DBD. Several pathogenic variants have been previously described in this domain (Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>). Differently, P2 showed a stop‐gain variant in exon 2 (c.729_730delinsCT; p.Gln244*) predicted to lead to nonsense‐mediated <italic>mRNA</italic> decay, since located at 50–55 nucleotides upstream of the last intron–exon junction (Lykke‐Andersen &amp; Jensen, <xref ref-type="ref" rid="embj2019104163-bib-0078">2015</xref>). A novel variant, 115 bases downstream of the initiation site and leading to a truncation (c.115G&gt;T; p.Glu39*), was identified in P3, while in the case of P4 a variant at the initiation site (c.2T&gt;C; p?) is anticipated to interrupt protein translation. A novel missense variant was also characterized in P5, located in the functional DBD zinc‐finger domain (c.292T&gt;C; p.Tyr98His), similarly to P1. Finally, P6 carries a missense variant, located in the LBD proximal to C‐terminal side and leading to protein truncation (c.967_968delAA; p.Lys323Serfs*73). In all patients, Sanger sequencing confirmed the <italic>de novo</italic> occurrence. No additional single nucleotide and gene copy number variant that could explain the phenotype was identified. All these patients depicted a reproducible and regional brain malformation defect, apart from P1, with very similar clinical features. Taken together, we introduced six new patients with <italic>NR2F1</italic> variants located at the initiation site, in the DBD and LBD, and showing similar clinical and brain malformation defects.</p>
</sec>
<sec id="embj2019104163-sec-0004">
<title>NR2F1 displays distinct expression gradients along the human brain axes and micro‐modules encompassing primary convolutions</title>
<p>The presence of local alterations in cortical folding of this new cohort of BBSOAS patients suggests that NR2F1 might act in a regionalized manner during the gyrification process. To this purpose, we investigated NR2F1 expression pattern in different cortical regions of human gestational week (GW) 11 and GW14 fetal sections. NR2F1 expression in apical and basal NP cells as well as differentiated neurons showed a clear latero‐posterior high to medio‐anterior low expression gradient (Figs <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>H and I, and <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>G–J), which reminds the same graded expression profile along the A‐P and L‐M brain axes previously described in mouse embryos (Armentano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0008">2006</xref>, <xref ref-type="ref" rid="embj2019104163-bib-0009">2007</xref>). Together with the high protein similarities between rodents and humans, these data support highly conserved expression patterns, and possibly function during evolution (Alzu'bi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0005">2017a</xref>,<xref ref-type="ref" rid="embj2019104163-bib-0006">b</xref>; Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0016">2018</xref>).</p>
<p>The human cortex differs from that of the mouse for its gyrencephalic pattern, i.e., the formation of gyri and sulci that allows an expansion of the total cortical surface (Sun &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0107">2014</xref>; Fernández <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0044">2016</xref>). The first neocortical folds (also called primary convolutions), such as the Sylvian or calcarine fissures as well as the parieto‐occipital sulcus, arise as early as GW9 (Kostovic &amp; Vasung, <xref ref-type="ref" rid="embj2019104163-bib-0068">2009</xref>; Sarnat &amp; Flores‐Sarnat, <xref ref-type="ref" rid="embj2019104163-bib-0102">2016</xref>), but are more evident between GW13 and GW15, when they display a cytoarchitectural organization of progenitors that reminds that of later secondary and tertiary gyri/sulci (Kostovic &amp; Vasung, <xref ref-type="ref" rid="embj2019104163-bib-0068">2009</xref>; Hansen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0056">2010</xref>; Zhang <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0123">2013</xref>; Vasung <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0117">2016</xref>; Kostović <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0067">2019</xref>). Basal radial glia (bRG), a specialized progenitor cell type able to produce a high number of neurons and abundantly represented in gyrencephalic species at the outer subventricular zone (oSVZ) (Hansen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0056">2010</xref>; Reillo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0098">2011</xref>; Pollen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0095">2015</xref>), possibly contribute to cortical folding in association with other progenitor parameters (Garcia‐Moreno <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0049">2012</xref>; Kelava <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0065">2012</xref>). The modular expression of some genes has been proved to control local abundance of neurogenic bRG cells, ultimately positioning gyri and sulci (de Juan Romero <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0061">2015</xref>). We found that NR2F1 expression levels are finely modulated around these developing primary folds (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>J–Q). While low NR2F1 levels are observed at prospective sulci (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>J, K′, N and P′), where SOX2<sup>+</sup> bRG and TBR2 + intermediate progenitor (IP) cells are very few (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>K–L″), NR2F1 levels increase in folded regions (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>J, L′ and Q), where a high amount of IP and bRG cells are formed together with increased neuronal production and tangential dispersion (Figs <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>P″ and R, and <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>K–L″). Hence, micro‐modules of low to medium/high NR2F1 levels are associated with distinct local distribution of progenitor types (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>L–L″) and specific abundance of cells expressing HOPX (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001">1</xref>P–R), a <italic>bona fide</italic> marker of human bRG cells (Pollen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0095">2015</xref>). These data suggest a modular and fine regulation of <italic>NR2F1</italic> expression levels around forming convolutions that could be associated with the process of cortical gyrification, as previously described for other genes (de Juan Romero <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0061">2015</xref>) (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>M).</p>
</sec>
<sec id="embj2019104163-sec-0005">
<title>Nr2f1‐mediated control of self‐renewal potential in mouse neurospheres</title>
<p>The high NR2F1 expression profile in NP cells and the finding of microgyral malformations in BBSOAS patients prompted us to investigate NR2F1 in NP physiology. In mouse, Nr2f1 has been previously shown to coordinate neurogenesis (Faedo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0043">2008</xref>); however, its exact function within the different NP populations and in cell cycle regulation has not been investigated so far. Hence, as a first step in assessing <italic>Nr2f1</italic> action in NP self‐renewal ability, we cultured NP‐derived neurospheres, representing free‐floating progenitor clusters, established from E15.5 <italic>Ctrl</italic> (<italic>WT</italic>) and <italic>Nr2f1null</italic> (<italic>KO</italic>) cortices (Armentano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0008">2006</xref>), and cultured for several passages in FGF2 and EGF‐containing medium (Reynolds <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0099">1993</xref>; Brewer &amp; Torricelli, <xref ref-type="ref" rid="embj2019104163-bib-0027">2007</xref>). Interestingly, while <italic>WT</italic> neurospheres expanded until step 5 and underwent exhaustion by step 9 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002">2</xref>A and B), <italic>Nr2f1 KO</italic> neurospheres displayed long‐term self‐renewal for more than 15 steps (up to 30 passages tested; Fig <xref ref-type="fig" rid="embj2019104163-fig-0002">2</xref>B). Besides their capacity of continuously self‐amplifying, <italic>Nr2f1</italic> mutant neurospheres were both more numerous and bigger in size (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002">2</xref>A); however, we reasoned that the latter parameter could be influenced by fusion of adjacent neurospheres. Thus, we dissociated some cell clusters and isolated single neurospheres to evaluate their independent growth (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002">2</xref>C): by day 6 of <italic>in vitro</italic> culture, single mutant neurospheres depicted a significantly bigger size compared to <italic>WT</italic> ones (10.2 ± 2.4% and 14.7 ± 1.7% diameter increase at day 6 and day 10, respectively; <italic>P</italic> = 0.002 and <italic>P</italic> = 0.003). This enhanced growth was associated with a doubled number of PH3<sup>+</sup> dividing NPs within the neurospheres (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002">2</xref>D and E). Enhanced mitotic activity was not dependent on the specific culture protocol used, as we detected an increased number of PH3<sup>+</sup> cells also when NPs were cultured as a monolayer (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S1A–C</xref>). These results show that NPs have increased self‐renewal capability upon <italic>Nr2f1</italic> loss, further reinforced by enhanced proliferation, and suggest that, normally, Nr2f1 might restrain self‐renewal potential of cortical NP cells.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<title>Nr2f1 regulates neural progenitor self‐renewal in a neurosphere assay</title>
<p>
<list id="embj2019104163-list-0003" list-type="simple"><list-item><label>A</label><p>Representative images of wild‐type (<italic>WT</italic>) and mutant (<italic>KO</italic>) neurospheres obtained from E15.5 neocortices and cultured <italic>in vitro</italic>. The culture passage (“step”) corresponds to 3 days of culture after dissociation and re‐plating. <italic>KO</italic> aggregates are more numerous and larger in size.</p></list-item><list-item><label>B</label><p>Graph showing the number of neurospheres per P100 cell plate at different steps, as indicated. <italic>Nr2f1 KO</italic> neurospheres proliferate for a longer time (up to 30 passages tested), whereas <italic>WT</italic> cells exhaust around step 9. <italic>n</italic> ≥ 3 culture plates from <italic>n</italic> = 2 batches.</p></list-item><list-item><label>C</label><p>Panel of <italic>WT</italic> and <italic>KO</italic> isolated neurospheres grown from day 1 to day 10. Blue and red lines represent the diameter of <italic>WT</italic> and <italic>KO</italic> neurospheres, respectively.</p></list-item><list-item><label>D, E</label><p>PH3 (green; dividing cells) IF on cross‐sections of day 4 neurospheres. White arrowheads point at mitotic figures, which are quantified in (E) as percentage of dividing cells over DAPI‐stained nuclei (blue). <italic>n</italic> ≥ 3 neurospheres from <italic>n</italic> = 2 batches.</p></list-item></list>Data information: In (B, E), data are represented as means ± SEM. Two‐way ANOVA (B) and Student's <italic>t</italic>‐test (E) (**<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. PH3: Phosphohistone H3.</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="EMBJ-39-e104163-g004"></graphic>
</fig>
</sec>
<sec id="embj2019104163-sec-0006">
<title>Progenitor pool amplification in <italic>Nr2f1 KO</italic> mutants leads to occipital neocortex expansion</title>
<p>To dissect the role of Nr2f1 in NP cell behavior <italic>in vivo</italic>, we directly quantified the number of proliferating progenitors in the neocortex of <italic>WT</italic> and <italic>Nr2f1 KO</italic> at different ages by using the proliferation marker Ki67 and focusing on the lateral pallium (LP) of posterior cortices, a region of highest <italic>Nr2f1</italic> expression from E9.5‐E10.5 (Tomassy <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0113">2010</xref>). Ki67<sup>+</sup> proliferating NPs increased in the mutant starting from E14.5 and were maintained in high numbers until P0 compared to <italic>WT</italic> brains (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>A–D). Different types of progenitors, such as apical radial glia (aRG) or bRG cells, contribute to neuronal production in a direct or indirect way via the generation of IP cells (Florio &amp; Huttner, <xref ref-type="ref" rid="embj2019104163-bib-0047">2014</xref>). To distinguish among NP subtypes, we stained mutant cortices for Pax6 (labeling aRGs next to the ventricular zone—VZ—or bRGs in subventricular zone—SVZ) and Tbr2 (a <italic>bona fide</italic> IP marker in SVZ). <italic>Nr2f1 KO</italic> cortices displayed a higher number of Pax6<sup>+</sup> RG cells from E12.5 to E17.5 compared to littermate controls (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>E–G), suggesting enhanced aRG self‐renewal. Notably, IP production (a good indicator of the start of neurogenesis) was delayed, as mutant cortices showed a peak of Tbr2<sup>+</sup> cells at E16.5, instead of E15.5 as in <italic>WT</italic> brains (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>H). Nevertheless, a high number of IPs were still maintained until birth (P0), indicating that IP‐dependent neurogenesis is taking place at later time points in mutant brains compared to <italic>WT</italic> ones (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>H). Interestingly, Pax6<sup>+</sup> Tbr2<sup>−</sup> bRGs, which are normally scarcely represented in murine brains (Reillo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0098">2011</xref>; Wang <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0118">2011</xref>), doubled their numbers in mouse mutant cortices at late developmental stages (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>F, F′ and I), possibly as a result of the overall Pax6<sup>+</sup> cell pool expansion. The identity of bRG cells was not only assessed by Sox2, Ki67, and Tbr2 triple labeling and by their basal position (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002ev">EV2</xref>A–G), but also by P‐Vimentin, which labels the apical process of dividing bRGs (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002ev">EV2</xref>H and H′). A fraction of mitotic bRGs in the mutant basal SVZ, here referred to as oSVZ, also expressed low levels of Tbr2 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0002ev">EV2</xref>I–K), in accordance with previous studies and suggesting the presence of bRGs converting into IPs <italic>in loco</italic> (Hansen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0056">2010</xref>; Stahl <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0104">2013</xref>). Interestingly, heterozygous (<italic>HET</italic>) embryos (lacking only one <italic>Nr2f1</italic> allele, hence more similar to BBSOAS patients) already showed a trend in increasing progenitor abundance during neocortical development (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003ev">EV3</xref>A–F). These results indicate that Nr2f1 regulates the number and local abundance of apical and basal NPs, notably Pax6<sup>+</sup> aRG and bRG cells, in a dosage‐dependent manner.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<title>Nr2f1‐mediated control of progenitor amplification <italic>in vivo</italic>
</title>
<p>
<list id="embj2019104163-list-0004" list-type="simple"><list-item><label>A–D</label><p>Ki67 (green; mitotically active progenitors) and Tuj1 (red; post‐mitotic neurons) IF at E14.5 (A, A′), E16.5 (B, B′), and E18.5 (C, C′) of lateral pallia of wild‐type (<italic>WT</italic>) versus mutant (<italic>KO</italic>) brains. Ki67<sup>+</sup> proliferating cells (quantified in D) accumulate in mutant cortices. <italic>n</italic> ≥ 3 brains.</p></list-item><list-item><label>E–E′</label><p>Tbr2 (green; IPs) and Pax6 (red; radial glia cells) IF of E13.5 (E, E′) and E17.5 (F, F′) lateral pallia of <italic>WT</italic> and <italic>KO</italic> brains. See Fig <xref ref-type="fig" rid="embj2019104163-fig-0003ev">EV3</xref> for Tbr2 Pax6 double staining in E17.5 <italic>HET</italic> embryos.</p></list-item><list-item><label>G–I</label><p>Quantification of different classes of cortical progenitors: apical radial glia cells (aRGs) as Pax6<sup>+</sup> NPs in VZ (G), basal intermediate progenitors (IPs) as Tbr2<sup>+</sup> cells in SVZ (H), and basal RGs as Pax6<sup>+</sup> cells in outer SVZ (I). See Fig <xref ref-type="fig" rid="embj2019104163-fig-0003ev">EV3</xref> for quantification of distinct progenitor classes in E17.5 <italic>HET</italic> embryos. <italic>n</italic> ≥ 3 brains.</p></list-item><list-item><label>J–L</label><p>E12.5 dorsal brain views (J, J′) and representative sections of posterior hemispheres (K, K′), showing a vesicle enlargement in mutant brains (K′). The extension of the ventricular surface was quantified along the A‐P axis (L); red color code represents Nr2f1 gradient in <italic>WT</italic> brains. 12 μm‐thick sections were collected on series of 10 slides; consecutive measurement levels are 120 μm apart from each other. <italic>n</italic> ≥ 3 brains.</p></list-item><list-item><label>M</label><p>Schematic representation of different aRG cell divisions, as visualized <italic>in vivo</italic> after co‐<italic>in utero</italic> electroporation (IUE) of <italic>Tis21‐RFP</italic> and <italic>Sox2‐GFP</italic> plasmids into E12.5‐old embryos. Green: symmetric proliferative divisions; yellow: asymmetric differentiative divisions; and red: symmetric differentiative divisions.</p></list-item><list-item><label>N–P</label><p>GFP (green; expressed under Sox2 promoter) and RFP (red; expressed under Tis21 promoter) IF of E13.5 lateral pallia, 18 h after IUE. The proportion of single‐ or double‐positive NPs is shown in pie charts in (P). <italic>n</italic> = 3 electroporated brains.</p></list-item><list-item><label>Q–R′</label><p>Ki67 (green; progenitors) and EdU (red) IF of E13.5 <italic>WT</italic> (Q, Q′) and <italic>KO</italic> (R, R′) embryos, injected with EdU at E12.5. Differentiating cells (EdU<sup>+</sup>Ki67<sup>−</sup>) are located in the IZ/CP; percentages shown in (Q′, R′) were obtained from <italic>n</italic> ≥ 4 sections of <italic>n</italic> ≥ 2 brains. See Fig <xref ref-type="fig" rid="embj2019104163-fig-0003ev">EV3</xref> for neural differentiation index of E13.5 <italic>HET</italic> embryos.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. In (D, G, H, I), the number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the LP. In graphs, data are represented as means ± SEM. Student's <italic>t</italic>‐test (Q′, R′; E13.5, EdU injected at E12.5; <italic>WT</italic>/<italic>KO</italic>: *<italic>P</italic> = 0.03967) and two‐way ANOVA (D, G, H, I, L, P) (*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. CP: cortical plate; IZ: intermediate zone; SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="EMBJ-39-e104163-g006"></graphic>
</fig>
<fig fig-type="Figure" id="embj2019104163-fig-0002ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV2</label>
<caption>
<title>Molecular identity of basal (b) RGs in Nr2f1 mutant cortices</title>
<p>
<list id="embj2019104163-list-0011" list-type="simple"><list-item><label>A–F</label><p>Tbr2 (green), Sox2 (red), and Ki67 (blue) triple IF of <italic>WT</italic> (A, C, E) and <italic>KO</italic> (B, D, F) neocortices at E16.5 (A–D) or at E18.5 (E, F) showing abundant NPs in mutant brains. bRGs located out of the Tbr2<sup>+</sup> SVZ layer are very abundant in the mutant lateral pallium (LP; arrowheads in B).</p></list-item><list-item><label>G</label><p>Average number of NPs with distinct molecular profiles in the LPs of E18.5 control and mutant embryos. Cells were evaluated separately in the VZ‐SVZ (left) and in the IZ basal to the Tbr2<sup>+</sup> SVZ layer (hereinafter oSVZ; right). A high number of Ki67<sup>+</sup>Sox2<sup>+</sup>Tbr2<sup>−</sup> NPs are found in the <italic>KO</italic> oSVZ, consistent with bRG identity. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>H–J</label><p>Tbr2 (green), Pax6 (red), and Phospho‐Vimentin (blue) triple IF of E17.5 <italic>WT</italic> (H, I) and <italic>KO</italic> (J) LPs. The typical morphology of a bRG cell is shown in (H) and magnified in (H′); gray arrowheads point to the apical process, and empty arrowhead highlights the Pax6<sup>+</sup> bRG soma. Note a high number of P‐Vim<sup>+</sup> cells in the oSVZ of <italic>KO</italic> embryos (J; arrowheads point to P‐Vim<sup>+</sup> cells).</p></list-item><list-item><label>K</label><p>Average number of dividing (P‐Vim<sup>+</sup>) cells in the LPs of E18.5 <italic>WT</italic> and <italic>KO</italic> embryos. Cells were evaluated separately in the VZ‐SVZ (left) and oSVZ (right). Mutant brains have a higher number of P‐Vim<sup>+</sup> cells expressing Pax6 or both Pax6 and Tbr2, and located in the VZ‐SVZ or in the oSVZ layer, respectively. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item></list>Data information: In (G, K), the number of positive cells was quantified in 200 μm‐ or 400 μm‐width boxes, as indicated, randomly placed across the LP. In graphs, data are represented as means ± SEM. Two‐way ANOVA (**<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. CP: cortical plate; IZ: intermediate zone; SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="EMBJ-39-e104163-g005"></graphic>
</fig>
<fig fig-type="Figure" id="embj2019104163-fig-0003ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV3</label>
<caption>
<title>Nr2f1 dose‐dependent control of progenitor amplification and differentiation <italic>in vivo</italic>
</title>
<p>
<list id="embj2019104163-list-0012" list-type="simple"><list-item><label>A–C</label><p>Tbr2 (green; IPs) and Pax6 (red; radial glia cells) IF of E17.5 lateral pallia of <italic>WT</italic> (A, A′), <italic>HET</italic> (B) and <italic>KO</italic> (C) brains.</p></list-item><list-item><label>D–F</label><p>Quantification of different classes of cortical progenitors in distinct genotypes as indicated; apical radial glia cells (aRGs) were quantified as Pax6<sup>+</sup> NPs in VZ (D), basal intermediate progenitors (IPs) as Tbr2<sup>+</sup> cells in SVZ (E), and basal RGs as Pax6<sup>+</sup> cells in outer SVZ (F). <italic>n</italic> ≥ 2 brains.</p></list-item><list-item><label>G–I′</label><p>Ki67 (green; progenitors) and EdU (red) IF of E13.5 <italic>WT</italic> (G‐G″), <italic>HET</italic> (H, H′), and <italic>KO</italic> (I, I′) embryos, injected with EdU at E12.5. Differentiating cells (EdU<sup>+</sup>Ki67<sup>−</sup>) are located in the intermediate zone (IZ) or in the cortical plate (CP).</p></list-item><list-item><label>J</label><p>Graph showing the average number of EdU<sup>+</sup>Ki67<sup>−</sup> differentiating cells in <italic>WT</italic> (blue column), <italic>HET</italic> (gray column), and <italic>KO</italic> (orange column) cortices quantified 24 h after EdU injection. Delayed at E13.5 in <italic>KO</italic> brains, neurogenesis shows a decreasing trend also in <italic>HET</italic> brains. The number of EdU<sup>+</sup>Ki67<sup>−</sup> differentiating cells was re‐normalized on total number of Ki67<sup>+</sup> cells, to factor‐in the increased size of progenitor pool in mutant brains compared to <italic>WT</italic>. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. The number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the LP. Data are represented as means ± SEM. Two‐way ANOVA (n.s.=not significant, <italic>P</italic> &gt; 0.05; *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. CP: cortical plate; IZ: intermediate zone; SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-15" xlink:href="EMBJ-39-e104163-g007"></graphic>
</fig>
<p>We next wondered whether aberrant proliferation of mutant NP cells affects the shape and volume of the early mouse cortex. Early proliferating aRGs normally expand the neuroepithelium tangentially while leaving the VZ thickness unchanged (Caviness, <xref ref-type="ref" rid="embj2019104163-bib-0035">2003</xref>). Consistently, the early NP increase in mutant brains was reflected by cortical hemisphere expansion, as confirmed in whole brains and in brain sections (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>J–K′). The hemisphere expansion was quantified by measuring the extension of the inner ventricle wall (dotted line in Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>K and K′). The hemisphere increased size was evident only in the posterior‐most region of the cortex (average 78.9 ± 18.3% posterior increase; <italic>P</italic> = 0.024), consistent with Nr2f1 highest expression in posterior cortex (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>L). Taken together, we found a regional increased number of NPs and an evident expansion of posterior hemispheres in early mouse <italic>Nr2f1</italic> mutant embryos.</p>
<p>The balance of symmetric versus asymmetric NP division is a fundamental process necessary to finely regulate brain neurogenesis and size (Götz &amp; Huttner, <xref ref-type="ref" rid="embj2019104163-bib-0053">2005</xref>; Matsuzaki &amp; Shitamukai, <xref ref-type="ref" rid="embj2019104163-bib-0083">2015</xref>). As the generation of Tbr2<sup>+</sup> basal IPs was delayed in mutants while the number of Pax6<sup>+</sup> cells was increased, we reasoned that <italic>Nr2f1</italic> loss could promote symmetric divisions, hence amplifying the apical progenitor pool at early time points. To confirm the self‐renewing ability of mutant progenitors, we employed an <italic>in utero</italic> electroporation (IUE) approach to directly visualize symmetrically dividing cells (self‐renewing) and asymmetrically dividing ones (undergoing neurogenesis), by means of <italic>Sox2‐GFP</italic> and <italic>Tis21‐RFP</italic> reporter plasmid co‐electroporations at E12.5 (Saade <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0100">2013</xref>). NP cells which are dividing symmetrically to self‐renew appeared as green cells (GFP<sup>+</sup>), whereas neurogenic divisions producing two neurons were labeled in red (RFP<sup>+</sup>) (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>M). Asymmetrically dividing NP pairs, in which one daughter cell self‐renews while the other one differentiates, expressed both plasmids resulting in a yellow signal (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>M). <italic>Nr2f1 KO</italic> brains showed a higher proportion of self‐renewing cells 18 h after IUE compared to <italic>WT</italic> electroporated littermates (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>N–P), indicating an abnormally longer process of symmetric divisions upon <italic>Nr2f1</italic> loss. Moreover, in a short‐term birth‐dating analysis, cortices injected with EdU at E12.5 and then stained for Ki67 24 h later showed a lower proportion of EdU<sup>+</sup>Ki67<sup>−</sup> cells exiting the cell cycle in <italic>KO</italic> embryos compared to <italic>WT</italic> littermates (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>Q–R′). Consistent with previous data, <italic>HET</italic> embryos depicted an intermediate effect (Fig <xref ref-type="fig" rid="embj2019104163-fig-0003ev">EV3</xref>G–J). These data strongly indicate that <italic>Nr2f1</italic> normally promotes asymmetric cell division and thus neurogenesis, and that in its absence NP cells divide symmetrically and expand their pool, ultimately delaying neurogenesis.</p>
</sec>
<sec id="embj2019104163-sec-0007">
<title>Increased neuronal output in the posterior hemispheres of mouse <italic>Nr2f1</italic> mutant brains</title>
<p>We then asked whether the highly proliferative NP pool observed in mouse mutant brains eventually undergoes neural differentiation, as suggested by delayed Tbr2 expression. To directly visualize differentiating cells, we injected EdU at given stages and evaluated the number of EdU<sup>+</sup>Ki67<sup>−</sup> cells reaching the intermediate zone (IZ) or the cortical plate (CP) 24 h later (short‐term EdU protocol; Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>A–D). While remaining significantly longer in the cell cycle at early stages (E12.5; Figs <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>Q–R′ and <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>A), mutant NPs generated a higher number of differentiating cells at later stages compared to <italic>WT</italic> (at E16.5 and P0; Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>A–C′). However, when evaluating neural differentiation as a fraction of the total EdU<sup>+</sup> population, we found no difference between <italic>WT</italic> and <italic>KO</italic> after E15.5 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>D). This suggests that the abnormal increased number of locally produced neurons after E15.5 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>A) is an indirect consequence of an amplified NP pool, rather than of a higher tendency to undergo differentiation. Consistent results (high neuronal production at mid‐late neurogenesis) were obtained with a long‐term EdU injection approach, in which EdU was injected at different embryonic ages and then evaluated at P0 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>E). To further reveal the type of neurons produced in <italic>KO</italic> cortices, we co‐labeled EdU<sup>+</sup> cells with layer‐specific markers and found that both early produced Tbr1<sup>+</sup> and later generated Cux1<sup>+</sup> neurons were over‐represented in mutant brains (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>F–G″), whereas the number of Ctip2<sup>+</sup> neurons was not affected (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>F–F″). Notably, cells produced at E17.5 still included high number of neurons in the mutant brain, together with slightly increased gliogenesis, as assessed by triple EdU GFAP NeuN labelling (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>H–J). As a consequence of intensive neurogenesis, mutant brains displayed a 27.1 ± 2.7% and 34.2 ± 1.7% increase in CP thickness at E17.5 and P0, respectively, and expanded occipital hemispheres (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>K–L″). Tuj1<sup>+</sup> post‐mitotic neuron numbers confirmed an initial delay in neurogenesis followed by a significant neuronal increase in <italic>KO</italic> cortices at following stages (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>L, L′ and M), and leading to the formation of a thicker posterior CP with over‐represented early‐ and late‐generated (Tbr1<sup>+</sup> and Satb2<sup>+</sup>) neurons (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004ev">EV4</xref>N–Q). Taken together, our data show that <italic>Nr2f1</italic> loss triggers a progenitor pool increase followed by a boost in neurogenesis, which correlates with an early lateral growth of the cortical neuroepithelium and a late radial expansion of the CP, globally leading to an occipital cortex enlargement.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0004ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV4</label>
<caption>
<title>Delayed neurogenesis and posterior cortical thickening in Nr2f1‐deficient mice</title>
<p>
<list id="embj2019104163-list-0013" list-type="simple"><list-item><label>A</label><p>Graph showing the average number of EdU<sup>+</sup>Ki67<sup>−</sup> differentiating cells in <italic>WT</italic> (blue columns) and <italic>KO</italic> (orange columns) cortices quantified 24 h after EdU injection. Delayed at E13.5, neurogenesis in <italic>KO</italic> brains increases significantly from E16.5 onwards. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>B–C′</label><p>Ki67 (green), EdU (red), and Satb2 (blue; cortical callosal neurons) triple IF of E16.5 <italic>WT</italic> (B, B′) and mutant (C, C′) embryos, injected 24 h before with EdU. Differentiating cells (EdU<sup>+</sup>Satb2<sup>+</sup>Ki67<sup>−</sup>) can be recognized as they migrate toward the CP.</p></list-item><list-item><label>D</label><p>Short‐term EdU injection as in (A), after re‐normalization on the total number of EdU<sup>+</sup> cells, to take account of the increased size of progenitor pool in mutant brains compared to <italic>WT</italic>. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>E</label><p>Average number of EdU<sup>+</sup> cells in the LP of control (blue columns) and mutant (orange columns) embryos at P0 upon EdU injection at the indicated stages. Mutant cortices are characterized by a higher density of differentiating neurons at mid‐late corticogenesis. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>F–F″</label><p>Ctip2 (green), Tbr1 (blue), and EdU (red; injected at E12.5) triple IF of P0 <italic>WT</italic> (F) and <italic>KO</italic> (F′) brains showing a high number of E12.5‐born Tbr1<sup>+</sup>EdU<sup>+</sup> neurons in lower layers of mutant cortices. Graph in (F″) quantifies the average number of EdU<sup>+</sup> neurons expressing distinct laminar markers (Tbr1 and Ctip2) in <italic>WT</italic> and <italic>KO</italic> embryos injected with EdU at E12.5. <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>G–G″</label><p>Cux1 (green) and EdU (red; injected at E15.5) double IF of P0 <italic>WT</italic> (G) and <italic>KO</italic> (G′) brains showing a high number of E15.5‐born Cux1<sup>+</sup>EdU<sup>+</sup> neurons in superficial layers of mutant cortices. Quantification of E15.5‐born Cux1<sup>+</sup> superficial neurons in <italic>WT</italic> and <italic>KO</italic> embryos is shown in (G″). <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>H–J</label><p>NeuN (green; neurons), EdU (red), and GFAP (blue; glia) triple IF of <italic>WT</italic> (H, H′) and <italic>KO</italic> (I, I′) animals injected at E17.5 and analyzed at P8. The average number of EdU<sup>+</sup>NeuN<sup>+</sup> neurons or of EdU<sup>+</sup>GFAP<sup>+</sup> glial cells is quantified in (J). <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>K, K′</label><p>Representative images of P0 <italic>WT</italic> (K) and <italic>KO</italic> (K′) brains, showing slight elongation of posterior hemispheres (compare red lines with blue ones).</p></list-item><list-item><label>L, M</label><p>Tuj1 (red) IF of <italic>WT</italic> (L) and <italic>KO</italic> (L′) cortices. Note the increased thickness of <italic>KO</italic> IZ and CP compared to <italic>WT</italic> ones. Graph in (L″) indicates CP thickness measured at E17.5 and P0 in the posterior cortical region of control (blue) and mutant (orange) animals. The average number of Tuj1<sup>+</sup> differentiating neurons in posterior‐most CP is quantified from E12.5 to P5 in (M). L″: <italic>n</italic> = 2 brains per genotype/age; M: <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>N–Q</label><p>Ctip2 (green), Tbr1 (blue), and Satb2 (red) triple IF of <italic>WT</italic> (N,N′,P) and <italic>KO</italic> (O,O′,P′) posterior cortices at P0 and P8, as indicated, and quantified in (Q). <italic>n</italic> ≥ 4 sections from <italic>n</italic> = 2 brains.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. Data are represented as means ± SEM. Two‐way ANOVA (*<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. CP: cortical plate; IZ: intermediate zone; SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-17" xlink:href="EMBJ-39-e104163-g009"></graphic>
</fig>
</sec>
<sec id="embj2019104163-sec-0008">
<title>Region‐specific control of cell cycle dynamics by Nr2f1</title>
<p>As part of its role in regulating neurogenesis, we reasoned that Nr2f1 could control the cell cycle length itself by setting the average mitotic activity along the A‐P neocortical axis. Key players of neocortical area mapping, such as Pax6 and Emx2, have been shown to finely regulate cell proliferation dynamics in a region‐specific manner, linking areal identity to specific cell cycle durations, neurogenic activities, and cell fate acquisition (Dehay &amp; Kennedy, <xref ref-type="ref" rid="embj2019104163-bib-0040">2007</xref>; Borrell &amp; Calegari, <xref ref-type="ref" rid="embj2019104163-bib-0023">2014</xref>). By quantifying different classes of PH3<sup>+</sup> progenitors at a stage when both apical and basal progenitors are present, we found no difference in anterior/motor regions, while mutant brains showed increased mitoses in posterior/sensory neocortical regions, where Nr2f1 is normally highly expressed (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005ev">EV5</xref>A–C).</p>
<fig fig-type="Figure" id="embj2019104163-fig-0005ev" orientation="portrait" position="float" specific-use="collapsible" xml:lang="en">
<label>Figure EV5</label>
<caption>
<title>Regional control of cell cycle dynamics</title>
<p>
<list id="embj2019104163-list-0014" list-type="simple"><list-item><label>A, B</label><p>Tbr2 (green; IPs) and PH3 (red; mitotic figures) double IF of E17.5 <italic>WT</italic> and <italic>KO</italic> posterior lateral pallia (LPs). Arrowheads in (A, B) point to PH3<sup>+</sup> mitotic NPs.</p></list-item><list-item><label>C</label><p>Average number of dividing cells in the LP of control (<italic>WT</italic>) and mutant (<italic>KO</italic>) animals in different regions along the A‐P axis, as indicated. E17.5 was chosen as a developmental age displaying abundant basal progenitor populations. Values of dividing aRGs, IPs, and bRGs are indicated in orange, yellow, and green, respectively. <italic>n</italic> ≥ 3 brains.</p></list-item><list-item><label>D</label><p>Experimental set‐up for cell cycle time quantification by double EdU/BrdU injection (adapted from Martynoga <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0082">2005</xref>). Ti corresponds to an interval time between EdU and BrdU injections. For detailed information, see Methods in the Appendix File.</p></list-item><list-item><label>E–E″</label><p>BrdU (green) and EdU (red) double IF of <italic>WT</italic>,<italic> HET,</italic> and <italic>KO</italic> E12.5 ventricular zone of LPs. Single EdU<sup>+</sup> cells (leaving fraction) that exit the S‐Phase during the 2‐h injection period move within the VZ surface (red arrowheads), while double EdU/BrdU label S‐phase cells reside in a more basal VZ position, next to the SVZ.</p></list-item><list-item><label>F, F′</label><p>Cell cycle duration along the A‐P axis of E12.5 (F) and E14.5 (F′) LP in mutant (<italic>KO</italic>) embryos and their control (<italic>WT</italic>) littermates. Cell cycle is accelerated (i.e., has a shorter duration) in NPs of the posterior‐most region of the mutant cortex, where Nr2f1 is expressed at high levels in control littermates. <italic>n</italic> ≥ 3 brains per age/genotype. Cell cycle time has been expressed in arbitrary units (A.U.) upon normalization on the WT Ant duration.</p></list-item><list-item><label>G</label><p>Cell cycle duration of E14.5 <italic>WT</italic>,<italic> HET,</italic> and <italic>KO</italic> LPs, showing a decreasing trend of cell cycle duration in <italic>HET</italic> animals and a significant decrease in <italic>KO</italic> ones compared to <italic>WT</italic> controls. <italic>n</italic> ≥ 2 brains.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. In (C, F‐G), the number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the LP. In graphs, data are represented as means ± SEM. Two‐way ANOVA (*<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. Ant: anterior; CP: cortical plate; IZ: intermediate zone; Med: medial; Post: posterior; SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-19" xlink:href="EMBJ-39-e104163-g011"></graphic>
</fig>
<p>To directly measure the cell cycle duration time, we employed a double EdU/BrdU protocol in which pregnant females are injected with EdU first, followed by BrdU 1.5 h later, and then sacrificed at 2 h to process treated embryos (Martynoga <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0082">2005</xref>; Mi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0084">2013</xref>) (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005ev">EV5</xref>D). The ratio of single EdU<sup>+</sup> or double EdU<sup>+</sup>BrdU<sup>+</sup> cells over the total number of Ki67<sup>+</sup> cycling cells in the neocortical neuroepithelium (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005ev">EV5</xref>E–E″) was used to estimate the cell cycle time (Tc, the time needed to complete a full cell cycle) in E12.5 and E14.5 brains. While the cell cycle duration was not altered in anterior‐most regions, it was instead greatly reduced in more posterior <italic>Nr2f1 KO</italic> cortices (33.5 ± 1.7% shorter Tc), implying an accelerated cell cycle of E12.5 and E14.5 <italic>KO</italic> brains (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005ev">EV5</xref>F and F′), with <italic>HET</italic> brains already showing a trend toward cell cycle acceleration (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005ev">EV5</xref>G). As an alternative approach, we employed fluorescence‐activated cell sorting (FACS), which evaluates the percentage of S‐, G2‐ and M‐phase cells after PH3 and propidium iodide staining (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S2</xref>). The number of cycling cells undergoing division (PH3<sup>+</sup>) or entering S‐and G2‐phases was higher in E17.5 mutant posterior cortex compared to <italic>WT</italic> (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S2A–D‴</xref>), with little or no difference in anterior halves of cortices, in line with the <italic>Nr2f1</italic> graded expression profile. At E14.5, cell cycle progression was accelerated by 10% in <italic>HET</italic> posterior cortices and by 17% in <italic>KO</italic> ones, compared to control samples (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S2E–G</xref>). Overall, these results show that Nr2f1 dosage links positional identity of cortical progenitors to distinct cell cycle dynamics.</p>
<p>Based on these data, we decided to focus on the posterior/occipital cortex, where cellular abnormalities were more pronounced, for further cell cycle analysis. We wondered whether Nr2f1‐dependent control of mitotic activity was taking place at specific time points. The total number of PH3<sup>+</sup> mitotic figures was higher in mutant cortices all along corticogenesis, especially from E14.5 to E17.5 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>A). By specifically quantifying mitoses in different compartments, we found increased divisions for both apical (Pax6<sup>+</sup>PH3<sup>+</sup> in VZ) and basal (Pax6<sup>+</sup>PH3<sup>+</sup> in oSVZ) RG cells. Tbr2<sup>+</sup> mitoses (SVZ) followed the same trend previously described for IP numbers, i.e., an initial delay in the mutant followed by high and sustained late activity (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>B–D). To assess whether and how Nr2f1 controls cell cycle duration during corticogenesis, we performed double EdU/BrdU injection from E10.5 to E16.5 and found that the cell cycle of mutant progenitors was mainly accelerated during early/mid‐neurogenesis (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>E). An EdU cumulative labeling approach in E13.5 posterior cortices (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>F–H), coupled with PH3 staining to visualize G2‐ and M‐phase cells (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>I–K), allowed us to precisely measure the duration of different cell cycle phases in VZ/SVZ NPs (Contestabile <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0038">2009</xref>) (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>L). Compared to <italic>WT</italic>,<italic> Nr2f1 KO</italic> NP cells had a slightly (14%) longer S‐phase, typical of “younger” self‐renewing progenitors (Calegari, <xref ref-type="ref" rid="embj2019104163-bib-0031">2005</xref>; Lange <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0073">2009</xref>; Arai <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0007">2011</xref>) (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>L). S‐phase lengthening was compensated by a significantly 31% shorter G1‐phase in the mutant, which resulted in an overall shorter cell cycle duration (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>L). Taken together, our data indicate that Nr2f1 operates a fine, region‐specific control of cell cycle progression along the A‐P axis, with strongest effects in the posterior/occipital neocortex. In its absence, cell cycle acceleration will contribute to altered cortical morphology, reminiscent of a posterior macrocephaly.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<title>Nr2f1 orchestrates cell cycle dynamics in posterior hemispheres</title>
<p>
<list id="embj2019104163-list-0005" list-type="simple"><list-item><label>A–D</label><p>Graphs showing the average number of PH3<sup>+</sup> mitotic figures in the posterior lateral pallium of <italic>WT</italic> and mutant cortices. The total number of mitoses (A) as well as the number of dividing cells in VZ (Pax6<sup>+</sup>Sox2<sup>+</sup> aRGs; B), SVZ (Tbr2<sup>+</sup> IPs; C), and outer (basal‐most) region of SVZ (oSVZ/IZ; Pax6<sup>+</sup> bRGs; D) is shown. For graphs (B‐D), statistical analysis by two‐way ANOVA is shown in <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Table S5</xref>. <italic>n</italic> ≥ 3 brains per age/genotype.</p></list-item><list-item><label>E</label><p>Cell cycle duration at different embryonic ages (from E10.5 to E16.5) in <italic>WT</italic> (blue bars) or <italic>KO</italic> embryos (orange line), as quantified upon a double EdU/BrdU injection protocol in posterior‐most LP (See Fig <xref ref-type="fig" rid="embj2019104163-fig-0005ev">EV5</xref>D–E″ and <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>). <italic>n</italic> ≥ 3 brains per age/genotype.</p></list-item><list-item><label>F–G′</label><p>Ki67 (green; NPs) and EdU (red) IF in <italic>WT</italic> (F,F′) and <italic>KO</italic> (G,G′) after 6 h consecutive EdU incorporation. Note the higher number of labeled NPs in <italic>KO</italic> cortices (G′) suggesting faster cell cycle progression and/or longer S‐phase.</p></list-item><list-item><label>H</label><p>Best linear fit of EdU<sup>+</sup>Ki67<sup>+</sup> NP percentage after 8 h EdU cumulative labeling in <italic>WT</italic> (blue line) and <italic>KO</italic> (orange line) brains. The x‐ and y‐intercepts are proportional to the S‐phase length and to the number of cycling cells, respectively, while the steepness of the line is proportional to cell cycle duration (see <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>; <italic>WT</italic>: y = 11.66x + 24.62; <italic>KO</italic>: y = 13.54x + 32.96). <italic>n</italic> ≥ 2 brains per time point/genotype.</p></list-item><list-item><label>I–K</label><p>PH3 (green; dividing NPs) and Pax6 (red; aRGs) IF of E13.5 <italic>WT</italic> (I) and <italic>KO</italic> (J) lateral pallia. Strong and weak/punctate PH3 patterns show M‐phase and G2‐phase cells, respectively. G2‐phase NP percentage is quantified in (K). As a result of shorter G1‐phase and globally shorter cell cycle time, the percentage of G2‐phase cells is increased in the <italic>KO</italic> NP pool. <italic>n</italic> ≥ 2 brains.</p></list-item><list-item><label>L</label><p>Cell cycle time of E13.5 NPs in the lateral pallia of <italic>WT</italic> (upper column) and <italic>KO</italic> cells (lower column), as calculated by EdU cumulative labeling and PH3 staining (see <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>). <italic>KO</italic> NPs have a 16.1% faster cell cycle time, due to a 30.9% shorter G1‐phase compensating a 14.3% longer S‐phase. <italic>n</italic> ≥ 3 brains.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. In (A‐E, H, K), the number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the lateral pallium. In graphs, data are represented as means ± SEM. Student's <italic>t</italic>‐test (K; *<italic>P</italic> &lt; 0.05) and two‐way ANOVA (A‐E, H, L) (*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm. SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-21" xlink:href="EMBJ-39-e104163-g008"></graphic>
</fig>
<p>Finally, we investigated whether Nr2f1 levels influenced NP cell physiology also along the L‐M neocortical axis, since Nr2f1 shows a lateral‐high to medial‐low gradient along the neocortical neuroepithelium, reaching highest levels in the latero‐ventral region (Armentano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0008">2006</xref>; Faedo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0043">2008</xref>). While different Nr2f1 levels correlated with distinct degrees of neurogenesis and NP populations along the L‐M axis (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3A–E</xref>), this gradient was partially lost following Nr2f1 removal (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3F</xref>). Interestingly, at E17.5, Sox2<sup>+</sup>Pax6<sup>+</sup> bRG cells were extremely abundant in the DP (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3G</xref>), which has been recently described as a gyrus‐like region of the mouse cortex for its abundant presence of Hopx<sup>+</sup> bRG cell population (Vaid <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0116">2018</xref>). On the contrary, bRGs were scarcely represented in the medial (MP) and lateral (LP) pallia (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3G</xref>). Upon Nr2f1 genetic inactivation, the L‐M distribution of bRGs was altered (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3H–K</xref>). Strikingly, the LP became populated by an abundant bRG cell population (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3H, J and K</xref>), suggesting the acquisition of a more “dorsal‐like” progenitor identity. Cell cycle length, as quantified by double EdU/BrdU injection at E14.5 (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3L–O</xref>), was significantly accelerated in the LP of mutant brains (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3O</xref>). The DP, characterized by intermediate Nr2f1 levels, showed a smaller but significant cell cycle acceleration (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3O</xref>). Taken together, our data indicate that cell cycle progression and progenitor ratios are finely tuned by Nr2f1 dosage along both the A‐P and L‐M axes (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3P</xref>).</p>
</sec>
<sec id="embj2019104163-sec-0009">
<title>Nr2f1‐mediated regulation of <italic>Pax6</italic> expression levels and cell cycle genes</title>
<p>Next, we aimed to identify some of the molecular mechanisms underpinning the high production of NP cells in posterior cortices of <italic>Nr2f1 KO</italic> mice. Pax6 plays a crucial role in controlling cell cycle and fate of both apical and basal NPs (Englund, <xref ref-type="ref" rid="embj2019104163-bib-0041">2005</xref>; Asami <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0010">2011</xref>; Mi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0084">2013</xref>). Since persistent Pax6 expression in basal progenitors promotes proliferation and neurogenesis (Wong <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0120">2015</xref>) and Pax6 levels can be modulated by Nr2f1 (Faedo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0043">2008</xref>; Tang <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0109">2010</xref>), we hypothesized that abnormally increased Pax6 expression levels might contribute to the occipital expansion observed in <italic>Nr2f1 KO</italic> brains. Indeed, we found increased Pax6 protein in the LP of E12.5 and E14.5 mutant brains (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>A–C; see also Fig <xref ref-type="fig" rid="embj2019104163-fig-0003">3</xref>E and E′), confirmed by a 33.3 ± 5.8% increase in <italic>Pax6</italic> transcript, as quantified by RT–PCR (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>D). Interestingly, <italic>Nr2f1 HET</italic> brains already showed a significant increase in Pax6 expression compared to <italic>WT</italic> littermates (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S4A–E</xref>), even if not reaching the same level of <italic>KO</italic> ones. To assess whether Nr2f1 can modulate Pax6 expression in a cell‐autonomous way, a <italic>Nr2f1</italic>‐overexpressing plasmid was electroporated into E12.5 cortices and Pax6 signal intensity evaluated in GFP<sup>+</sup> cells 24 h later (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>E–G″). GFP<sup>+</sup> progenitors with high Nr2f1 expression down‐regulated Pax6 (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>H), confirming that Nr2f1 cell‐autonomously restrains Pax6 expression levels in cortical progenitor cells.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<title>Nr2f1‐mediated molecular control of neural progenitors (NPs)</title>
<p>
<list id="embj2019104163-list-0006" list-type="simple"><list-item><label>A–B′</label><p>Pax6 (green; aRGs) and Nr2f1 (red) IF of E12.5 <italic>WT</italic> (A, A′) and <italic>KO</italic> (B, B′) lateral pallia. See <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S4</xref> for Pax6 and Nr2f1 staining and pixel intensity quantification in <italic>HET</italic> embryos.</p></list-item><list-item><label>C</label><p>Pax6 and Nr2f1 pixel intensity quantification at E12.5 and E14.5 indicating increased Pax6 levels upon Nr2f1 removal. <italic>n</italic> ≥ 3 brains.</p></list-item><list-item><label>D</label><p>Real‐time RT–PCR quantification of Nr2f1 and Pax6 expression in E12.5 cortices. <italic>n</italic> ≥ 3 cortices.</p></list-item><list-item><label>E–G″</label><p>GFP (green; electroporated cells), Pax6 (red), and Nr2f1 (blue) IF of <italic>pCIG2‐Nr2f1‐IRES‐GFP</italic> electroporated brains at E13.5 (24 h after IUE). VZ (F‐F″) and CP (G‐G″) regions are shown at high magnification. Arrowheads point to GFP<sup>+</sup> electroporated cells overexpressing Nr2f1 (blue in F′, G′), down‐regulating Pax6 (F″), and rapidly migrating out of the VZ (G‐G″).</p></list-item><list-item><label>H</label><p>Scatter plot showing Pax6 and Nr2f1 pixel intensity of VZ electroporated progenitors, comparing Nr2f1 overexpressing cells (orange dots) with control <italic>pCIG2‐GFP</italic> electroporated cells (blue dots). Average Nr2f1 and Pax6 pixel intensities of the 2 populations were compared by two‐way ANOVA and resulted significantly different (***<italic>P</italic> = &lt; 0.0001). <italic>n</italic> = 2 electroporated brains.</p></list-item><list-item><label>I</label><p>Real‐time RT–PCR of cell cycle genes comparing <italic>WT</italic> (blue line) and <italic>KO</italic> (orange line) cortices. <italic>CyclinD1</italic> and <italic>P21</italic> transcripts are down‐regulated, whereas <italic>Dct</italic> is up‐regulated in mutants. <italic>n</italic> = 3 cortices.</p></list-item><list-item><label>J–L</label><p>GFP (green; electroporated cells) and P21 (red) IF of E14.5 cortex electroporated 48 h earlier with control <italic>PX458</italic> plasmid (J) or CRISPR/Cas9‐expressing plasmid directed against Nr2f1 sequence (<italic>PX458‐αNr2f1</italic>; K). Percentage of P21/GFP double‐positive cells (L). Arrowheads in (J, K) point to P21<sup>+</sup> cells. <italic>n</italic> = 2 electroporated brains.</p></list-item><list-item><label>M</label><p>Schematic model of Nr2f1 action on NP cell cycle and neural differentiation. Nr2f1 promotes neurogenesis by repressing Pax6 and Dct expression and thus cell cycle progression, and by activating P21‐mediated cell cycle exit. Both actions modulate the G1‐phase length.</p></list-item><list-item><label>N</label><p>Graph showing the number of differentially expressed genes (DEG; see <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>) up‐regulated (UP) or down‐regulated (DOWN) in <italic>KO</italic> compared to <italic>WT</italic>, as detected by <italic>RNA‐Seq</italic> of E15.5 neocortices.</p></list-item><list-item><label>O</label><p>Gene ontology (GO) categories significantly enriched among DEG genes (<italic>DAVID Gene Ontology software</italic>; see <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>).</p></list-item><list-item><label>P</label><p>Hierarchical clustering and heatmap of the expression level of DEGs belonging to the “neuron differentiation” GO category in (O). Heat map color scale indicates normalized gene expression from high (red) to low (white) level.</p></list-item></list>Data information: In (A, B, J, K), nuclei (blue) were stained with DAPI. In (C), the pixel intensity was quantified in 100 μm‐width boxes, randomly placed across the lateral pallium. Data are represented as means ± SEM. Student's <italic>t</italic>‐test (L; *<italic>P</italic> &lt; 0.05) and two‐way ANOVA (C, D, H, I) (*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). For statistical analysis of <italic>RNA‐Seq</italic> data (N‐P), see <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>. Scale bars: 50 μm. SVZ: subventricular zone; VZ: ventricular zone.</p>
</caption>
<graphic id="nlm-graphic-23" xlink:href="EMBJ-39-e104163-g010"></graphic>
</fig>
<p>Furthermore, since <italic>Nr2f1</italic> mutant NP cells show accelerated cell cycle progression, we investigated the expression of several key cell cycle genes by RT–PCR on E12.5 posterior cortices (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>I). While most genes failed to show any significant differences between E12.5 <italic>WT</italic> and <italic>KO</italic> brains, we nevertheless observed altered expression of some interesting candidates involved in cell proliferation and cell cycle control, such as <italic>DCT</italic>,<italic> CycD1,</italic> and <italic>P21</italic> (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>I). The dopachrome tautomerase enzyme DCT has been previously demonstrated to be essential for promoting NP proliferation (Jiao <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0060">2006</xref>); hence, its increase could be partially responsible for the increased mitotic index of mutant cells. Moreover, the expression of <italic>cyclin D1</italic> (<italic>CycD1</italic>), an essential regulator of the G1–S transition phase, was also affected in the mutant (43.7% lower compared to <italic>WT</italic>; Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>I). Since <italic>CycD1</italic> expression is particularly high during the G1‐phase (Glickstein <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0051">2007</xref>), its diminution could depend on the G1‐phase shortening observed in <italic>KO</italic> cells (Fig <xref ref-type="fig" rid="embj2019104163-fig-0004">4</xref>L). Interestingly, <italic>Nr2f1 KO</italic> cortices revealed decreased <italic>P21</italic> expression compared to <italic>WT</italic> counterparts (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>I). The cyclin‐dependent kinase inhibitor P21 is considered an inducer of neurogenesis, as it is transiently expressed in a subset of NPs to trigger cell cycle exit and differentiation (Siegenthaler, <xref ref-type="ref" rid="embj2019104163-bib-0103">2005</xref>). To support a causal relationship between Nr2f1 and P21, we acutely down‐regulated <italic>Nr2f1</italic> via IUE of a CRISPR/Cas9 plasmid (herein called <italic>PX458‐αNr2f1</italic>) in which the single guide RNA (<italic>sgRNA</italic>) recognizes the ATG starting codon of the <italic>Nr2f1</italic> gene, hence targeting and disrupting the sequence necessary for its translation (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S5</xref>). Nr2f1 expression was down‐regulated or completely abolished in GFP<sup>+</sup> electroporated cells (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S5A–C</xref>), indicating CRISPR/Cas9‐mediated loss of one or two <italic>Nr2f1</italic> alleles, respectively. Upon <italic>PX458‐αNr2f1</italic> IUE, we found a 59.5 ± 11.3% drop in the number of P21<sup>+</sup> cells undergoing neurogenesis (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>J–L). Together, we showed that Nr2f1 exerts its control on NP proliferation by modulating both cortical area patterning genes (such as <italic>Pax6</italic>) and distinct cell cycle genes (such as <italic>P21</italic>) (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>M).</p>
<p>Moreover, as <italic>NR2f1</italic> mutants display multiple deficits in addition to changes in cell cycle, we decided to employ a full transcriptomic profile analysis to have a more comprehensive picture of genetic changes upon <italic>Nr2f1</italic> loss. We compared <italic>WT</italic> and <italic>KO</italic> cortical transcriptomics by <italic>RNA‐Seq</italic> at E15.5, a key stage of neurogenesis. Among differentially expressed genes (DEGs; see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S6 and Appendix Table S1</xref>), 102 and 68 were significantly up‐ and down‐regulated, respectively (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>N). Gene ontology (GO) analysis of DEG genes highlighted “neuron differentiation” and “neuron development” as most significant categories (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>O; see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Tables S2–S4</xref> for complete results), in line with the role played by Nr2f1 during neurogenesis. GO analysis by Panther Overrepresentation analysis or by Ingenuity pathway analysis showed similar results, additionally highlighting “axonal guidance signaling” and “netrin signaling” as highly regulated categories (<xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Tables S3 and S4</xref>). The “neuron differentiation” GO category included known master genes of neurogenesis as well as cell adhesion, NP delamination, and axon guidance, such as <italic>Rorb</italic>,<italic> Ephb3</italic>,<italic> Sema6a,</italic> and <italic>Slit3</italic> (Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>P). Interestingly, the third GO category (“MAPK signaling pathway”) suggests that Nr2f1 could orchestrate NP proliferation, fate, and differentiation in an indirect way by regulating signaling pathways with broader action (Begemann &amp; Michon, <xref ref-type="ref" rid="embj2019104163-bib-0012">1995</xref>; Faedo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0043">2008</xref>), in addition to specific cell cycle or cortical master genes. Further functional studies are needed to validate Nr2f1 target genes and/or regulated pathways.</p>
</sec>
<sec id="embj2019104163-sec-0010">
<title>Genetic manipulation of Pax6 levels rescues both <italic>in vitro</italic> self‐renewal potential and <italic>in vivo</italic> cell cycle dynamics of Nr2f1‐deficient NP cells</title>
<p>To directly investigate whether Pax6 acts as a major effector downstream of Nr2f1 during cortical NP proliferation, we genetically decreased Pax6 expression levels by crossing a <italic>Pax6 null</italic> line (St‐Onge <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0106">1997</xref>) with the <italic>Nr2f1</italic> mutant line. To aim for a functional rescue, we looked for a decrease and not a full loss of Pax6 levels in a <italic>Nr2f1 KO</italic> background. First, we measured <italic>Pax6 mRNA</italic> levels in neurospheres obtained from E15.5 dissociated <italic>Pax6</italic> mutant cortices and confirmed progressive diminished levels in heterozygous (<italic>Pax6 HET</italic>) and <italic>null</italic> (<italic>Pax6 KO</italic>) neurospheres (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>A). As expected, <italic>Pax6</italic> expression was increased in <italic>Nr2f1 KO</italic> neurospheres, and subsequent removal of one <italic>Pax6</italic> allele (<italic>Nr2f1 KO</italic>,<italic> Pax6 HET</italic>; Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>A) efficiently decreased <italic>Pax6</italic> transcripts in a <italic>Nr2f1 KO</italic> background. Interestingly, <italic>Nr2f1 KO</italic>,<italic> Pax6 HET</italic> neurospheres were smaller and proliferated for maximum up to 10 passages (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>B and C), indicating that Nr2f1‐dependent modulation by Pax6 levels is key for NP self‐renewal. To directly investigate the self‐renewing ability of mutant progenitors, we dissociated neurospheres and plated NP cells at low density to perform a paired‐cell test. Double Map2 and BLBP staining identified neuronal and progenitor cells, respectively, in newly dividing cell couples (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>D–D″), assessing differentiation versus self‐renewal. Isolated progenitors from <italic>Nr2f1 KO</italic> neurospheres generated a higher number of P‐P (symmetric proliferative) cell divisions, at the expense of P‐N (asymmetric) and N‐N (symmetric differentiative) ones, confirming a higher tendency of mutant NPs to self‐renew compared to <italic>WT</italic> ones (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>E). However, when one <italic>Pax6</italic> allele was removed, cell division proportions went back to levels comparable to <italic>WT</italic> cells with a reduced number of symmetric proliferative divisions (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>E). This indicates that Pax6 and Nr2f1 agonistically control the self‐renewal efficiency of dividing NP cells in the developing neocortex.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<title>Functional rescue of NP cell cycle dynamics via Pax6 genetic modulation</title>
<p>
<list id="embj2019104163-list-0007" list-type="simple"><list-item><label>A</label><p>Real‐time RT–PCR analysis of <italic>Pax6</italic> expression in neurospheres with different genotypes, as indicated. <italic>n</italic> = 3 cortices. <italic>N KO, P HET</italic>:<italic> Nr2f1 KO, Pax6 HET</italic>.</p></list-item><list-item><label>B</label><p>Representative images of <italic>Nr2f1 KO Pax6 HET</italic> neurospheres obtained from E15.5 neocortices and cultured <italic>in vitro</italic>.</p></list-item><list-item><label>C</label><p>Graph showing the number of neurospheres per P100 cell plate, at different steps, as indicated. While <italic>Nr2f1 KO</italic> neurospheres (orange line) proliferate for a longer time compared to <italic>WT</italic> ones (blue line), the loss of one <italic>Pax6</italic> allele (gray line) almost restores normal proliferation rate and exhaustion time. Complete <italic>Pax6</italic> loss is not compatible with stem cell renewal (yellow line). <italic>n</italic> ≥ 3 culture wells from <italic>n</italic> = 2 independent batches.</p></list-item><list-item><label>D, E</label><p>Paired‐cell analysis after neurosphere dissociation and 24‐h culture at clonal density. Couples of dividing cells were identified by Map2 (red; N, neurons) and BLBP (green; P, progenitors) IF. Pie charts in (E) show the proportion of P‐P (proliferative; D), P‐N (asymmetric differentiative; D′), or N‐N (symmetric differentiative; D″) couples in <italic>WT</italic>,<italic> Nr2f1KO,</italic> and <italic>Nr2f1KO Pax6 HET</italic> animals. <italic>n</italic> ≥ 3 samples from <italic>n</italic> = 2 culture batches.</p></list-item><list-item><label>F–I</label><p>Pax6 (green) and Nr2f1 (red) IF in the posterior‐most region of E12.5 cortex, showing Pax6 upregulation in <italic>Nr2f1 KO</italic> animals (G, G′) compared to <italic>WT</italic> (F′, F″). Normal Pax6 levels can be restored by loss of one Pax6 allele (<italic>Nr2f1 KO, Pax6 HET</italic>; H, H′). Pixel intensity quantification of Nr2f1 (blue) and Pax6 (orange) is shown in (I). <italic>n</italic> ≥ 3 brains. <italic>N KO: Nr2f1 KO; P HET</italic>:<italic> Pax6 HET</italic>.</p></list-item><list-item><label>J</label><p>Cell cycle duration at E12.5 in different mutants as indicated, quantified in posterior regions with double EdU/BrdU injection protocol (see <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref>). <italic>n</italic> ≥ 6 sections from <italic>n</italic> = 2 brains.</p></list-item><list-item><label>K</label><p>Insets showing representative γ‐Tubulin (green) and phospho‐Vimentin (red) IF of the cortical VZ surface to evaluate the orientation of the cleavage plane of dividing aRGs. Pie charts show the percentage of vertical (green), oblique (yellow), and horizontal (red) division planes of mitotic figures in the E12.5 lateral pallium of animals with different genotypes, as indicated. <italic>n</italic> ≥ 2 brains per genotype.</p></list-item></list>Data information: Nuclei (blue) were stained with DAPI. In (I, J), the pixel intensity or the number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the LP. Data are represented as means ± SEM. Two‐way ANOVA (A, C, E, I, J, K; *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). For statistical analysis of (E, K), see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Table S5</xref>. Scale bars: 50 μm.</p>
</caption>
<graphic id="nlm-graphic-25" xlink:href="EMBJ-39-e104163-g012"></graphic>
</fig>
<p>We next wondered whether cell cycle progression was also affected in brains with high or low Pax6 levels. As for neurospheres, we removed one <italic>Pax6</italic> allele to restore almost normal protein levels in the LP of E12.5 <italic>Nr2f1 KO</italic> cortices (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>F–H′; pixel intensity quantification in Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>I). By double EdU/BrdU incorporation, we evaluated the cell cycle duration in different mutants: while the cell cycle was shorter in <italic>Nr2f1 KO</italic> posterior cortices, it slowed back to a normal rate after removal of one <italic>Pax6</italic> gene copy (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>J). Interestingly, <italic>Pax6 HET</italic> animals displayed an even longer cell cycle time compared to <italic>WT</italic> (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>J), suggesting that, differently to what reported for more anterior cortical regions (Georgala <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0050">2011</xref>; Mi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0084">2013</xref>), Pax6 can act as a cell cycle accelerator in posterior cortex. Finally, we tested whether Pax6 modulation could rescue Nr2f1‐dependent control of NP cell division <italic>in vivo</italic>. We visualized the cleavage plane of dividing NPs by labeling them for P‐Vim and γ‐Tubulin to evaluate their division angle (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>K). A vertical cleavage plane has been associated with symmetric divisions originating two identical pluripotent daughter cells, whereas oblique or horizontal cleavage planes are mainly linked to neurogenesis, as they give rise to basal progenitors and neurons (Noctor <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0086">2008</xref>; LaMonica <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0071">2013</xref>; Florio &amp; Huttner, <xref ref-type="ref" rid="embj2019104163-bib-0047">2014</xref>; Matsuzaki &amp; Shitamukai, <xref ref-type="ref" rid="embj2019104163-bib-0083">2015</xref>). <italic>Nr2f1 KO</italic> NPs tended to divide more often through a vertical cleavage plane compared to <italic>WT</italic> ones, indicative of increased self‐renewal activity (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>K). Upon loss of one <italic>Pax6</italic> allele, the division plane of dividing NPs <italic>in vivo</italic> was however restored to levels similar to <italic>WT</italic> (Fig <xref ref-type="fig" rid="embj2019104163-fig-0006">6</xref>K). Together, our data indicate that key proliferative features of <italic>Nr2f1</italic> mutant progenitors can be rescued by lowering Pax6 levels. This implies that a complex network of interconnected key area mapping genes is required for the correct neurogenic activity to take place in a time‐ and region‐specific manner.</p>
</sec>
<sec id="embj2019104163-sec-0011">
<title>NR2F1 controls neurogenesis in human brain organoids</title>
<p>To investigate whether human NR2F1 is also able to regulate neurogenesis, we used <italic>in vitro</italic> 3D cerebral organoids, which recapitulate some of the major characteristics of early human brain development (Lancaster <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0072">2013</xref>; Wang, <xref ref-type="ref" rid="embj2019104163-bib-0119">2018</xref>; Klaus <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0066">2019</xref>). Immunostaining of human iPS‐derived organoids showed increased NR2F1 expression levels from day 30/40 to day 70 of <italic>in vitro</italic> differentiation (Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>A–C), as well as distinct protein levels with higher expression in NPs than in post‐mitotic neural cells (Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>B–B″), in accordance with our previous expression data (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>G′, G″, I′ and I″). Notably, day 40 neuroepithelia also displayed distinct NR2F1 protein levels in function of PAX6 expression (low NR2F1 level in high PAX6‐expressing neuroepithelia, and <italic>vice versa</italic>; Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>D–G), suggesting that the complementary expression profile between NR2F1 and PAX6 is most likely an evolutionary conserved process.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0007" orientation="portrait" position="float" xml:lang="en">
<label>Figure 7</label>
<caption>
<title>Delayed neurogenesis upon NR2F1 down‐regulation in human brain organoids</title>
<p>
<list id="embj2019104163-list-0008" list-type="simple"><list-item><label>A–C</label><p>NR2F1 expression in cerebral organoids during neural induction and differentiation <italic>in vitro</italic> (day 40 and day 70, respectively), together with the NP markers PAX6 (green in A), SOX2 (green in B, B′), and DCX as a neural marker (blue in A, B, B″). Quantification of NR2F1 levels in NPs is shown in (C). <italic>n</italic> ≥ 4 organoids from <italic>n</italic> = 2 batches.</p></list-item><list-item><label>D–G</label><p>NR2F1 (red) and PAX6 (green) IF in day 40 organoids. Neuroepithelia with high NR2F1 levels show weak PAX6 expression (E, E′), and <italic>vice versa</italic> (F, F′). Quantification by pixel intensity analysis (G). <italic>n</italic> ≥ 4 organoids from <italic>n</italic> = 2 batches.</p></list-item><list-item><label>H</label><p>Schematic representation of an organoid electroporation. <italic>PX458</italic> plasmids were injected in ventricular‐like cavities, and organoids were electroporated and processed after 7 days of <italic>in vitro</italic> culture.</p></list-item><list-item><label>I, J</label><p>NR2F1 (red) and GFP (green) IF in day 40 human brain organoids upon electroporation of the <italic>PX458‐αNR2F1</italic> plasmid. In (I, I′), GFP<sup>+</sup>NR2F1<sup>−</sup> cells (empty arrowheads) and a GFP<sup>+</sup>NR2F1<sup>+</sup> cell (white arrowhead) are shown; quantification in (J). <italic>n</italic> ≥ 6 organoids from <italic>n</italic> = 2 batches.</p></list-item><list-item><label>K–M</label><p>TUJ1 (red; differentiating neurons) and GFP (green) IF 7 days after electroporation of control (K) and <italic>PX458‐αNr2f1</italic> plasmids (L). Co‐expression of GFP with SOX2 or TUJ1 distinguishes neural progenitors (NPs) from neurons (Ns), as quantified in (M). Arrowheads in (K, L) point to TUJ1<sup>+</sup> GFP<sup>+</sup> cells. <italic>n</italic> ≥ 6 organoids from <italic>n</italic> = 2 batches.</p></list-item><list-item><label>N</label><p>Red and green arrowheads in (N) point to a SOX2<sup>+</sup> (red) progenitor and a TUJ1<sup>+</sup> (blue) neuron, respectively.</p></list-item></list>Data information: Nuclei (blue in D, I, K, L) stained with DAPI. In (C, G, J), the pixel intensity or the number of positive cells was quantified in 100 μm‐width boxes, randomly placed across the cortex/organoid neuroepithelia, while in (M) the number of positive cells was normalized over the total number of GFP<sup>+</sup> cells. In graphs, data are represented as means ± SEM. Two‐way ANOVA test (*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001). Scale bars: 50 μm.</p>
</caption>
<graphic id="nlm-graphic-27" xlink:href="EMBJ-39-e104163-g013"></graphic>
</fig>
<p>To start investigating NR2F1 role in human progenitors, we electroporated the CRISPR/Cas9 plasmid (<italic>PX458‐αNR2F1</italic>) into day 33‐cultured cerebral organoids, taking advantage of the high (100%) sequence conservation between mouse and human, and analyzed NR2F1 expression 7 days later (Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>H–J). The control experiment consisted in electroporating the empty <italic>PX458</italic> plasmid, without <italic>sgRNA</italic> sequence directed against <italic>NR2F1</italic> sequence. As in mouse cortex, the plasmid efficiently down‐regulated NR2F1 expression (Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>I and J), confirming that the <italic>PX458‐αNR2F1</italic> vector can modulate NR2F1 expression both in mouse brain and human organoids. Next, we evaluated protein levels of the NP marker SOX2 and of the neuronal marker TUJ1 in GFP<sup>+</sup> control‐ and <italic>PX458‐αNR2F1</italic>‐electroporated cells. We found that decreased NR2F1 levels were associated with increased tendency of progenitors to remain in the cell cycle and express SOX2 or PAX6, together with a reduced differentiation rate of double TUJ1<sup>+</sup>GFP<sup>+</sup> cells (Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>K–N). Indeed, the number of GFP<sup>+</sup> progenitor cells was increased at the expense of TUJ1<sup>+</sup> 7 days after IUE (Fig <xref ref-type="fig" rid="embj2019104163-fig-0007">7</xref>M), similarly to what previously shown in mouse embryos. Overall, this is a first step demonstrating the evolutionary conservation between mice and humans of NR2F1 as a major regulator of cortical neurogenesis through modulation of the NP pool and PAX6 expression levels.</p>
</sec>
</sec>
<sec id="embj2019104163-sec-0012">
<title>Discussion</title>
<p>Altered balance of cell proliferation, differentiation and neuron migration can lead to cortical malformations, often associated with a huge variety of clinical manifestations, such as intellectual disability (ID), schizophrenia, epilepsy, and/or autism spectrum disorder (Barkovich <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0011">2012</xref>; Sun &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0107">2014</xref>; Parrini <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0093">2016</xref>; Juric‐Sekhar &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0062">2019</xref>). Thanks to human genetic and animal model studies, it is now well accepted that macrocephaly, polymicrogyria, and/or microcephaly can be due to alterations in progenitor cell behavior (Boland <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0021">2007</xref>; Finding of Rare Disease Genes (FORGE) Canada Consortium <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0045">2012</xref>; Lee <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0074">2012</xref>; Poduri <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0094">2012</xref>; Mirzaa <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0085">2013</xref>; Marchese <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0080">2014</xref>; Terrone <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0111">2016</xref>), as also recently confirmed by 3D‐cell culture assays (Lancaster <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0072">2013</xref>; Li <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0075">2017</xref>). Moreover, advances in DNA sequencing technologies and concurrent improved resolution of neuroimaging techniques have allowed the identification of more genes and signaling pathways underlying different types of MCDs (Juric‐Sekhar &amp; Hevner, <xref ref-type="ref" rid="embj2019104163-bib-0062">2019</xref>). In this study, we aimed to investigate the cellular and molecular mechanisms underlying brain malformations of an emerging neurodevelopmental disease, called BBSOA syndrome, in which patients (mainly children) show clinical features of ID, epilepsy, repetitive behaviors, speech problems, and autistic‐like traits. A previous report focused on the optic atrophy defect (Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0017">2019</xref>), an important component of the clinical phenotype (Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>), but nothing was known on whether <italic>NR2F1</italic> haploinsufficiency would lead to particular types of cortical malformations. In this study, we describe a new cohort of BBSOAS patients who show a reproducible area‐specific folding defect resembling polymicrogyria and restricted to supramarginal and angular gyri, a region known to be involved in a number of processes related to language, spatial cognition, memory retrieval, attention, and number processing (Stoeckel <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0105">2009</xref>; Oberhuber <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0089">2016</xref>). NR2F1 is expressed in a modular fashion along primary convolutions, particularly in neurogenic bRG cells, and its down‐regulation affects neural differentiation in human brain organoids. In the mouse, precise levels of Nr2f1 are necessary for maintaining the delicate balance between proliferative and differentiative cells via the control of key patterning genes and cell cycle modulators. Thus, we propose NR2F1 as a novel regulator of cell proliferation and human cortical folding acting predominantly in an area‐specific manner during early development.</p>
<sec id="embj2019104163-sec-0013">
<title>Regional modulation of the progenitor pool size by a Nr2f1 expression gradient</title>
<p>Our data show that precise Nr2f1/NR2F1 levels along the A‐P axis correlate with specific profiles of progenitor abundance and their neurogenic activity in both mouse and human brains. In this study, we thoroughly assessed the effects of mouse Nr2f1 removal on cell cycle progression in the posterior cortex, where Nr2f1 is expressed at its highest level (Armentano <italic>et al</italic>, 2006; Tomassy <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0113">2010</xref>). Nr2f1 promotes asymmetric divisions by regulating cell cycle progression, hence modulating the progenitor pool amplification during cortical development. Upon loss of Nr2f1, the posterior‐most region undergoes extensive and prolonged proliferation, followed by delayed neurogenesis and high neuronal production, ultimately leading to extended occipital hemispheres (model in Fig <xref ref-type="fig" rid="embj2019104163-fig-0008">8</xref>A and B). The expansion of occipital convolutions described in P1 and P2 is somehow reminiscent to the posterior macrocephaly we describe in the mouse and could be the result of similar mechanisms of progenitor pool expansion, due to cell cycle acceleration and delayed neurogenesis. Thus, we propose that precise expression levels of NR2F1 are fundamental for the correct and area‐specific balance between progenitor self‐amplification and neurogenesis. Indeed, intermediate Nr2f1 expression levels in the dorsal pallial region, recently described as a gyrus‐like structure and characterized by an abundance of Hopx<sup>+</sup> cells (Vaid <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0116">2018</xref>), seem to be appropriate to trigger efficient neurogenesis, while concomitantly allowing basal progenitor amplification (summarized in <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Fig S3P</xref>). In human embryos, NR2F1 expression initially spans the A‐P and L‐M axes of the developing neocortex, but local modules of precise NR2F1 levels are associated with distinct degrees of neurogenesis and bRG populations during formation of primary convolutions. Hence, medium dosage of NR2F1 localized in developing folds could provide a “neurogenic boost”, which would trigger high neuronal output while allowing sustained cell proliferation, both necessary for cortical expansion and folding (Fig <xref ref-type="fig" rid="embj2019104163-fig-0001ev">EV1</xref>M). We thus propose NR2F1 as a novel modulator of progenitor cell production, including bRGs, in distinct localized regions.</p>
<fig fig-type="Figure" id="embj2019104163-fig-0008" orientation="portrait" position="float" xml:lang="en">
<label>Figure 8</label>
<caption>
<title>Schematic representation of cortical cellular and morphological consequences upon Nr2f1 loss</title>
<p>
<list id="embj2019104163-list-0009" list-type="alpha-upper"><list-item><p>Nr2f1 is expressed along an anteromedial‐low to posterolateral‐high gradient (red color code) in the developing mouse cortex, spanning from VZ aRGs to SVZ IPs, bRGs, and CP neurons. Upon Nr2f1 removal (<italic>KO</italic>), the NP pool of the posterior cortex expands leading to occipital macrocephaly.</p></list-item><list-item><p>Early to late effects on progenitor and neuron behavior upon Nr2f1 deficiency. Early in development (E10.5‐E12‐5), Nr2f1 loss causes cell cycle acceleration, increased NP self‐renewal, and sustained Pax6 expression. Neurogenesis (as well as the expression of neurogenetic factors such as Tbr2 and P21) is delayed, thus allowing amplification of the progenitor pool and lateral expansion of the posterior hemispheres. At later stages (E13.5‐E14.5), neurogenesis comes into play and neurons are produced at high rate. Persistent Pax6 expression in the expanded NP population leads to abundant basal RG production at late time points (E16.5‐E18.5). High neuronal output results in radial expansion and generation of a thick posterior cortex.</p></list-item></list>
</p>
</caption>
<graphic id="nlm-graphic-29" xlink:href="EMBJ-39-e104163-g014"></graphic>
</fig>
<p>However, our finding that <italic>Nr2f1</italic> loss in the mouse leads to an amplification of progenitors, notably aRG and bRG cells, seems apparently contradictory to the initial observation that NR2F1 in human cortex is highly expressed in bRG‐rich gyri. The two observations can be reconciled by interpreting the role of NR2F1/Nr2f1 as a pro‐neurogenic factor. Medium–high levels of human NR2F1 in cortical folds correlate with high abundance of bRGs and thus with high neurogenesis, whereas low NR2F1 levels in sulci are associated with low neurogenesis. In the mouse, complete Nr2f1 loss results in prolonged proliferation and delayed neural differentiation, consistent with the idea that Nr2f1 is promoting neurogenesis. Hence, the specific consequence of murine <italic>Nr2f1</italic> loss on radial glia amplification represents an indirect effect of enhanced cell proliferation associated with sustained Pax6 levels and is thus only apparently controversial with high NR2F1 expression in human bRG cells.</p>
</sec>
<sec id="embj2019104163-sec-0014">
<title>The role of Nr2f1 in cell cycle control</title>
<p>Previous reports have linked cell cycle progression to fate acquisition. Neural progenitors with longer S‐phase and shorter G1‐phase undergo self‐renewal instead of neurogenesis (Calegari, <xref ref-type="ref" rid="embj2019104163-bib-0031">2005</xref>; Lange <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0073">2009</xref>; Arai <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0007">2011</xref>). Consistently, neural progenitors in <italic>Nr2f1</italic> mutants, showing accelerated cell cycle due to a shorter G1‐phase, increase the progenitor pool by symmetric division, while neurogenesis is delayed. Cyclin‐dependent kinase inhibitor P21 is normally up‐regulated in NPs lengthening the G1‐phase and exiting the cell cycle to differentiate (Siegenthaler, <xref ref-type="ref" rid="embj2019104163-bib-0103">2005</xref>; Buttitta &amp; Edgar, <xref ref-type="ref" rid="embj2019104163-bib-0029">2007</xref>; Heldring <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0057">2012</xref>); hence, P21 down‐regulation in Nr2f1‐deficient progenitors could explain a delay in neurogenesis observed in mutant brains. Interestingly, we found that specific cell cycle durations are associated with regional abundance of progenitor subtypes, such as bRG cells in the dorsal pallium. Consistently, a link between increased proliferation and expansion of basal progenitor population, ultimately resulting in macrocephaly, was demonstrated in a mouse model in which the cell cycle progression was artificially and transiently accelerated (Nonaka‐Kinoshita <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0087">2013</xref>). It is tempting to speculate that specific cell cycle dynamics might be required for regionalized bRG amplification and that Nr2f1 levels could be key for controlling both cell cycle time and apico‐basal progenitor ratio in an area‐specific fashion.</p>
</sec>
<sec id="embj2019104163-sec-0015">
<title>NR2F1‐mediated control of PAX6 in mouse and human brains</title>
<p>Our molecular characterization indicates that Nr2f1/NR2F1 inhibits Pax6/PAX6 in mouse and human brain primordia, respectively. In mouse, Pax6 is known to act not only as an area patterning gene but also as a key regulator of cell cycle duration (Mi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0084">2013</xref>; Estivill‐Torrus <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0042">2002</xref>), cell division plane (Asami <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0010">2011</xref>), and progenitor activity (Englund, <xref ref-type="ref" rid="embj2019104163-bib-0041">2005</xref>; Wong <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0120">2015</xref>). Sustained Pax6 expression generates bRG in the developing neocortex (Wong <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0120">2015</xref>), in line with our data. However, it must be noted that Pax6 seems to act as a break for cell cycle progression (Georgala <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0050">2011</xref>), which is then accelerated in <italic>Pax6 Sey</italic> mice (Mi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0084">2013</xref>). On the contrary, we found that lowering Pax6 expression slows down cell cycle progression and restores normal cell cycle time in the posterior cortex of <italic>Nr2f1</italic> mutants. Hence, Nr2f1 and Pax6 might play different roles in function of their reciprocal area‐specific co‐expression levels, as previously suggested for Pax6 (Bishop, <xref ref-type="ref" rid="embj2019104163-bib-0018">2000</xref>; Bishop <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0019">2002</xref>; Zembrzycki <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0122">2007</xref>; Sansom <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0101">2009</xref>; Asami <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0010">2011</xref>). High Pax6 expression in anterior cortex directly correlates with low Nr2f1 expression, and <italic>vice versa</italic> in posterior cortex, and a complementary expression pattern between NR2F1 and PAX6 can also be reproduced in human cerebral organoids. Accordingly, functional modulation of Nr2f1 affects Pax6 expression in mouse, in line with previous findings (Faedo <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0043">2008</xref>; Tang <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0109">2010</xref>).</p>
<p>Finally, while endogenous Nr2f1 levels follow the neurogenic gradient along the L‐M axis, this is not the same for the A‐P axis; the occipital‐most cortex, expressing highest <italic>Nr2f1</italic> levels, has a delayed development compared to the anterior cortex with very low levels of this gene. We believe that <italic>Nr2f1</italic> gradient expression along the A‐P axis is more related to acquiring a distinct areal identity than to modulating neurogenesis, in line with its recognized role as a “sensory” mapping gene (Alfano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0003">2014</xref>). <italic>Pax6</italic> would be instead responsible for promoting neurogenesis in the anterior‐most cortex by controlling cell cycle parameters, as previously shown (Mi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0084">2013</xref>). It is well recognized that the regulation of the tangential extent of individual areas, as well as their precise neuronal pool, is under the control of cell cycle duration and rate of cell cycle re‐entry of progenitors (Lukaszewicz <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0500">2005</xref>). Hence, reciprocal regulation of early cortical master genes, such as <italic>Pax6</italic> and <italic>Nr2f1</italic>, would control the regional expansion of progenitor cell types, ultimately orchestrating regional and area‐specific growth (Cadwell <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0030">2019</xref>).</p>
</sec>
<sec id="embj2019104163-sec-0016">
<title>Regional gyral pattern abnormalities in NR2F1‐haploinsufficient patients</title>
<p>In this study, we report six novel cases of patients carrying NR2F1 mutations who are affected by ID and other cognitive disorders (Table <xref ref-type="table" rid="embj2019104163-tbl-0001">1</xref>). Patients display multiple cognitive symptoms together with optic nerve atrophy, a key feature of BBSOAS (Bosch <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0025">2014</xref>; Chen <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0036">2016</xref>). Here, we expand the clinical features of the BBSOA syndrome by describing for the first time some subtle but consistent brain malformations, such as aberrant cortical folding of the supramarginal and angular gyri and elongated occipital convolutions, in a new cohort of BBSOAS patients. Some phenotypic traits described in the six new patients, such as speech difficulties, stereotypical movements, and hyperactivity, are consistent with malformations in those specific regions (Stoeckel <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0105">2009</xref>; Oberhuber <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0089">2016</xref>). In spite of the impossibility to obtain high‐resolution MRI images for all patients, we speculate that similar brain malformations might be shared among other BBSOAS patients. The abnormal gyral pattern we have observed in our cohort of patients, which is not associated with cortical thickness abnormalities, does not completely fall under the classical description of PMG or other MCDs (Manzini &amp; Walsh, <xref ref-type="ref" rid="embj2019104163-bib-0079">2011</xref>; Barkovich <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0011">2012</xref>). However, canonical MCD classifications proposed to date not always encompass the high morphological heterogeneity described in patients with abnormal microgyria (Guerrini &amp; Dobyns, <xref ref-type="ref" rid="embj2019104163-bib-0055">2014</xref>).</p>
<p>A direct implication of NR2F1 in the development and positioning of cortical folds could not be tested in the mouse model. In fact, lissencephalic brains, such as the murine one, are not suitable and/or permissive systems to interrogate cortical folding, as they normally develop a smooth surface. While manipulation of few genes can nevertheless trigger cortical convolutions (Stahl <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0104">2013</xref>; Florio <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0048">2015</xref>; del Toro <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0114">2017</xref>) and/or greatly amplify basal progenitor abundance (Borrell, <xref ref-type="ref" rid="embj2019104163-bib-0024">2018</xref>), genetic misexpression more often results in a general increase or decrease of the murine cortical size, without surface bending (Groszer, <xref ref-type="ref" rid="embj2019104163-bib-0054">2001</xref>; Kwon <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0070">2006</xref>; Lange <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0073">2009</xref>; Tokuda <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0112">2011</xref>; preprint: Gompers <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0052">2016</xref>). Consistently, down‐regulating <italic>Nr2f1</italic> in the mouse leads to occipital macrocephaly by acting on cell cycle progression and progenitor pool size, but these changes were not selectively affecting the bRG population and thus inducing cortical gyrification. Genes inducing folding in gyrencephalic species have been shown to be expressed in local modules, predictive of gyri and sulci positioning (de Juan Romero <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0061">2015</xref>). Accordingly, human NR2F1 is both expressed along macro‐gradients (A‐P and L‐M axes) and locally modulated in micro‐modules; hence, NR2F1 could provide a link between positional identity of distinct neocortical areas and local formation of gyri and sulci. We speculate that abnormally low levels of <italic>NR2F1</italic> could lead to accelerated cell cycle progression and altered ratio of distinct progenitor subtypes, resulting in specific types of cortical malformations, such as elongated occipital convolutions or PMG‐like abnormalities. However, to directly demonstrate NR2F1 involvement in cortical folding, more experimental approaches will be required in the future, such as the use of ferret, a gyrencephalic animal model previously employed for challenging the formation of cortical convolutions (Nonaka‐Kinoshita <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0087">2013</xref>; de Juan Romero <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0061">2015</xref>; Fernández <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0044">2016</xref>).</p>
</sec>
<sec id="embj2019104163-sec-0017">
<title>Conclusion</title>
<p>Our BBSOAS mouse model has disclosed increased proliferative progenitor activity in the occipital cortex, due to sustained Pax6 expression together with delayed P21‐dependent block of cell cycle progression. Even if the involvement of a similar genetic pathway needs to be validated in human brains, our first data on brain organoids (this study, and M. Bertacchi and M. Studer, manuscript in preparation) point to that direction.</p>
</sec>
</sec>
<sec id="embj2019104163-sec-0018">
<title>Materials and Methods</title>
<sec id="embj2019104163-sec-0019">
<title>Study approval</title>
<p>The individuals and families with BBSOAS were recruited through multiple French clinical genetics centers. Written informed consent was obtained from the legal guardians of the probands, according to the Declaration of Helsinki. All experiments involving the use of human samples conformed to the principles set out in the WMA Declaration of Helsinki and the Department of Health and Human Services Belmont Report. Fetal tissues were kindly provided by Cécile Allet and Paolo Giacobini (Lille, France) and were made available in accordance with French bylaws (Good practice concerning the conservation, transformation, and transportation of human tissue to be used therapeutically, published on December 29, 1998); studies on human fetal tissue were approved by the French agency for biomedical research (See Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0017">2019</xref>; “Agence de la Biomédecine, Saint‐Denis la Plaine”, France, protocol no.: PFS16–002). All mouse experiments were conducted in accordance with relevant national and international guidelines and regulations (European Union rules; 2010/63/UE) and have been approved by the local ethical committee in France (CIEPAL NCE/2019‐548).</p>
</sec>
<sec id="embj2019104163-sec-0020">
<title>Mouse cell culture</title>
<p>Embryonic neocortical tissue was isolated at E12.5 or E15.5, dissociated, and cultured in neurospheres following previous protocols (Reynolds <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0099">1993</xref>; Brewer &amp; Torricelli, <xref ref-type="ref" rid="embj2019104163-bib-0027">2007</xref>). As an alternative to neurosphere culture, NPs were dissociated by trypsin digestion and seeded as a monolayer on a Matrigel‐coated plastic surface (Conti <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0039">2005</xref>).</p>
</sec>
<sec id="embj2019104163-sec-0021">
<title>Human brain organoids</title>
<p>Human induced pluripotent stem (iPS) cells and brain organoids were obtained and cultured as previously described (Lancaster <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0072">2013</xref>; Klaus <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0066">2019</xref>).</p>
</sec>
<sec id="embj2019104163-sec-0022">
<title>Immunofluorescence</title>
<p>Mouse embryonic brains/whole heads were processed for immunostaining, as previously described (Armentano <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0008">2006</xref>, <xref ref-type="ref" rid="embj2019104163-bib-0009">2007</xref>; Terrigno <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0110">2018</xref>). Primary and secondary antibodies used are listed in detailed <xref ref-type="sec" rid="embj2019104163-sec-0018">Materials and Methods</xref> (see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix File</xref>). Images were acquired at an Apotome Zeiss, using the AxioVision software.</p>
</sec>
<sec id="embj2019104163-sec-0023">
<title>EdU/BrdU injection and cell cycle time calculation</title>
<p>The nucleoside analogs EdU (5‐ethynyl‐2′‐deoxyuridine) and BrdU (5‐bromo‐2′‐deoxyuridine) were both injected at 10 mg/kg intraperitoneally in pregnant females carrying embryos at the desired age. For the calculation of cell cycle time, we followed a previously described protocol (Martynoga <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0082">2005</xref>). For cumulative EdU cell cycle quantification (Nowakowski <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0088">1989</xref>; Takahashi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0108">1993</xref>; Contestabile <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0038">2009</xref>), E13.5 embryos were labeled with multiple EdU injections (at 0, 2, 4, and 6 h). In all protocols listed, EdU was detected using EdU click‐iT technology (Invitrogen, C10340), while BrdU required acid antigen retrieval (30 min at 37°C in 2N HCl with 0.5% Triton X‐100) followed by immunostaining (Sigma B8434, 1:1,000, mouse). Detailed version of these protocols can be found in the Appendix File.</p>
</sec>
<sec id="embj2019104163-sec-0024">
<title>
<italic>In utero</italic> electroporation (IUE)</title>
<p>IUE was performed on E12.5 mouse brains targeting the latero‐dorsal regions of the telencephalic dorsal pallium. Conditions of electroporation have been previously described (Parisot <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0091">2017</xref>; Terrigno <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0110">2018</xref>). The <italic>Sox2p‐GFP</italic> and <italic>Tis21p‐RFP</italic> plasmids were a kind gift of E. Marti and G. Le Dréau (Saade <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0100">2013</xref>). For <italic>Nr2f1</italic> knock‐out/knock‐down, we used a CRISPR/Cas9 vector (Ran <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0097">2013</xref>) in <italic>wild‐type</italic> background mice. The anti‐Nr2f1 <italic>sgRNA</italic> probe for the CRISPR/Cas9 construct (cloning primers: CACCgcgagatccgcaggacgacg; AAACcgtcgtcctgcggatctcgc) was selected and checked for specificity <italic>in silico</italic> with Crispor (<ext-link ext-link-type="uri" xlink:href="http://crispor.tefor.net/">http://crispor.tefor.net/</ext-link>) and then cloned in the PX458 empty vector (Addgene; pSpCas9(BB)‐2A‐GFP).</p>
</sec>
<sec id="embj2019104163-sec-0025">
<title>Electroporation of organoids</title>
<p>Human brain organoids were kept in neural differentiation medium without antibiotics for 2 h before the experiment. The organoids were then placed in an electroporation chamber (Harvard Apparatus, Holliston, MA, USA), and the plasmid DNA was injected at a concentration of 1 μg/μl in several positions (Cárdenas <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0033">2018</xref>; Klaus <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0066">2019</xref>). The organoids were then subjected to five pulses at 80 V with a 50‐ms duration in an interval of 500 ms using an ECM830 electroporation device (Harvard Apparatus).</p>
</sec>
<sec id="embj2019104163-sec-0026">
<title>Cell cytometry</title>
<p>Neocortices were dissected on ice and digested using a Worthington Papain Dissociation System (Serlabo technologies LK003150), following manufacturers’ instructions. Low‐bind Eppendorf tubes were used to limit material loss. Dissociated single cells were washed twice with ice‐cold PBS 1X, then fixed by slowly adding ethanol while mixing on a vortex, and stored at −20°C. For cytometric analysis, cells were immunostained following the same immunofluorescence protocol used for cryostat sections, with the only difference that a brief centrifugation (5 min at 170 <italic>g</italic>) was performed between each solution change to recover the cells at the bottom of Eppendorf tubes and discard the supernatant. Cells were analyzed with BD LSRFortessa and FACSDiva software (Becton Dickinson) on the basis of 10,000 total events (debris excluded).</p>
</sec>
<sec id="embj2019104163-sec-0027">
<title>RNA‐Seq</title>
<p>Total RNA was extracted using TRIzol reagent (Invitrogen), and its integrity was analyzed by using the DNF‐471 Standard Sensitivity RNA Analysis Kit on Fragment Analyzer instrument (Advanced Analytical Technology, Ankeny, IA, USA). <italic>RNA‐Seq</italic> libraries were prepared from total <italic>RNA</italic> using <italic>TruSeq RNA</italic> Sample Preparation v2 (Illumina, San Diego, CA, USA) according to the manufacturer's protocol and sequenced on an Illumina <italic>NextSeq 500</italic> platform (Illumina). Sequencing reads were trimmed out of the low‐quality bases with <italic>FASTX‐Toolkit</italic> and mapped on mm9 genome assembly by using <italic>TopHat v2.0.6</italic> (Johns Hopkins University, Baltimore, MD, USA). Differentially expressed genes (DEG) were called by using DESeq2 software (Love <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0077">2014</xref>) (see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Table S1</xref> for complete list of DEG genes). Genes with a <italic>P</italic> &lt; 0.01 were considered for downstream Gene Ontology (GO) analysis (see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Tables S2–S4</xref> for GO analysis with DAVID web software, Ingenuity pathway analysis, or Panther Overrepresentation test, respectively). GO analysis showed in Fig <xref ref-type="fig" rid="embj2019104163-fig-0005">5</xref>O was performed by using DAVID web software (Huang <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0058">2009</xref>).</p>
</sec>
<sec id="embj2019104163-sec-0028">
<title>Statistics</title>
<p>All data were statistically analyzed and graphically represented using Microsoft Office Excel software and GraphPad Prism (version 7.00). Quantitative data are shown as the mean ± standard error (SEM). For cell percentage/number quantification after immunofluorescence (IF), measurements were performed on at least 9 sections coming from 3 to 5 different animals, unless otherwise stated (see <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Table S5</xref> for details). To minimize subjective bias, sample identity (e.g., genotypes) was randomized by associating an identification number to each sample before processing. Fixed embryos with damaged tissues were excluded from any further analysis/processing. Microscope images were processed with Photoshop or ImageJ software, by randomly overlapping fixed‐width (100 μm) rectangular boxes on the area of interest (e.g., the lateral pallium of the neocortex), then quantifying positive cells inside the boxes. When calculating percentages over the total cell number, the latter was quantified by counting DAPI<sup>+</sup> nuclei, unless otherwise specified. Data were compared by two‐tailed Student's <italic>t</italic>‐test (when comparing two data groups) or by two‐way ANOVA (analysis of variance; for comparison of three or more groups), and statistical significance was set as follows: *<italic>P </italic>≤<italic> </italic>0.05; **<italic>P </italic>≤<italic> </italic>0.01; ***<italic>P </italic>≤<italic> </italic>0.001. Sample size, statistical test used, and detailed list of statistical results for each experiment are listed in <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Table S5</xref>.</p>
</sec>
<sec id="embj2019104163-sec-0029">
<title>Real‐time RT–PCR</title>
<p>Neocortices were dissected in ice‐cold PBS1X and stored at −80°C. Total RNA was extracted with NucleoSpin RNA II columns (Macherey‐Nagel). Analysis was performed as previously described (Bertacchi <italic>et al</italic>, <xref ref-type="ref" rid="embj2019104163-bib-0013">2013</xref>, <xref ref-type="ref" rid="embj2019104163-bib-0014">2015a</xref>,<xref ref-type="ref" rid="embj2019104163-bib-0015">b</xref>). Primer sequences are listed in <xref ref-type="supplementary-material" rid="embj2019104163-sup-0001">Appendix Table S6</xref>.</p>
</sec>
</sec>
<sec id="embj2019104163-sec-0032">
<title>Author contributions</title>
<p>MS and MB conceived and designed the research project. MB, ALR, AL, CF, and RDG performed experiments and collected data. MB, ALR, AL, and MS analyzed data. RDG and SC provided experimental material and contributed to data analysis and discussion. FTM‐T, MW, PKK, LF, PK, CP, LP, AG, FD, AS, and CF were involved in the clinical investigation and identification of BBSOAS patients. MS, CF, FTM‐T, and LD'I supervised patient data collection and analyzed MRI scans. FN and SO performed and analyzed the <italic>RNA‐Seq</italic> transcriptomics. MB prepared manuscript figures. MB and MS wrote the manuscript. All authors provided critical review of results and approved the manuscript.</p>
</sec>
<sec id="embj2019104163-sec-0033" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data"></supplementary-material>
<supplementary-material content-type="local-data" id="embj2019104163-sup-0001">
<caption>
<p>Appendix</p>
</caption>
<media xlink:href="EMBJ-39-e104163-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="embj2019104163-sup-0002">
<caption>
<p>Expanded View Figures PDF</p>
</caption>
<media xlink:href="EMBJ-39-e104163-s002.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<caption>
<p>Review Process File</p>
</caption>
<media xlink:href="EMBJ-39-e104163-s003.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="embj2019104163-sec-0031">
<title>Acknowledgements</title>
<p>We are grateful to E. Setti for technical help and F. Calegari for insightful comments. We thank E. Marti and G. Le Dréau for the <italic>Sox2‐GFP</italic> and <italic>Tis21‐RFP</italic> plasmids, A. Mansouri for the <italic>Pax6 null</italic> line, and Salsabiel El Nagar for cell cycle primers. We also thank the iBV animal facility and especially A. Martres and K. Moneret for animal handling and care, the PRISM Microscopy facility for their regular support, and V. Virolle at the molecular biology facility for the generation of the <italic>PX458 αNr2f1 CRISPR/Cas9</italic> plasmid. Cryostat sections of human samples were kindly provided by C. Allet and P. Giacobini (Lille, France). This work was supported by an ERA‐NET Neuron II grant (ImprovVision) ANR‐15‐NEUR‐0002‐04, by the Jerome Lejeune Foundation (grant No. 199162), and by “Investments for the Future” LabEx SIGNALIFE (grant ANR‐11‐LABX‐0028‐01) to MS and by a postdoctoral fellowship from the city of Nice, France (“Aides Individuelles aux Jeunes Chercheurs”), to MB. The visit of MB in the Lab of SC to perform human organoid experiments was supported by an EMBO short‐term fellowship (STF#8035).</p>
</ack>
<sec id="embj2019104163-sec-0030" sec-type="data-availability">
<title>Data availability</title>
<p>The <italic>RNA‐Seq</italic> datasets produced in this study are available in the following database: Gene Expression Omnibus GSE146595 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146595">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE146595</ext-link>).</p>
</sec>
<ref-list content-type="cited-references" id="embj2019104163-bibl-0001">
<title>References</title>
<ref id="embj2019104163-bib-0001">
<mixed-citation id="embj2019104163-cit-0001" publication-type="journal">
<string-name>
<surname>Alfano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Viola</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Heng</surname>
<given-names>JI‐T</given-names>
</string-name>, <string-name>
<surname>Pirozzi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Clarkson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Flore</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>De Maio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schedl</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Guillemot</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2011</year>) <article-title>COUP‐TFI promotes radial migration and proper morphology of callosal projection neurons by repressing Rnd2 expression</article-title>. <source xml:lang="en"/>Development
<volume>138</volume>: <fpage>4685</fpage>–<lpage>4697</lpage>
<pub-id pub-id-type="pmid">21965613</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0002">
<mixed-citation id="embj2019104163-cit-0002" publication-type="journal">
<string-name>
<surname>Alfano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2013</year>) <article-title>Neocortical arealization: evolution, mechanisms, and open questions: evolution and development of neocortical areas</article-title>. <source xml:lang="en"/>Dev Neurobiol
<volume>73</volume>: <fpage>411</fpage>–<lpage>447</lpage>
<pub-id pub-id-type="pmid">23239642</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0003">
<mixed-citation id="embj2019104163-cit-0003" publication-type="journal">
<string-name>
<surname>Alfano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Magrinelli</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Harb</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hevner</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2014</year>) <article-title>Postmitotic control of sensory area specification during neocortical development</article-title>. <source xml:lang="en"/>Nat Commun
<volume>5</volume>: <fpage>5632</fpage>
<pub-id pub-id-type="pmid">25476200</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0004">
<mixed-citation id="embj2019104163-cit-0004" publication-type="journal">
<string-name>
<surname>Al‐Kateb</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shimony</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Vineyard</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Manwaring</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kulkarni</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shinawi</surname>
<given-names>M</given-names>
</string-name> (<year>2013</year>) <article-title>
<italic>NR2F1</italic> haploinsufficiency is associated with optic atrophy, dysmorphism and global developmental delay</article-title>. <source xml:lang="en"/>Am J Med Genet A
<volume>161</volume>: <fpage>377</fpage>–<lpage>381</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0005">
<mixed-citation id="embj2019104163-cit-0005" publication-type="journal">
<string-name>
<surname>Alzu'bi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lindsay</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kerwin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Looi</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Khalil</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Clowry</surname>
<given-names>GJ</given-names>
</string-name> (<year>2017a</year>) <article-title>Distinct cortical and sub‐cortical neurogenic domains for GABAergic interneuron precursor transcription factors NKX2.1, OLIG2 and COUP‐TFII in early fetal human telencephalon</article-title>. <source xml:lang="en"/>Brain Struct Funct
<volume>222</volume>: <fpage>2309</fpage>–<lpage>2328</lpage>
<pub-id pub-id-type="pmid">27905023</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0006">
<mixed-citation id="embj2019104163-cit-0006" publication-type="journal">
<string-name>
<surname>Alzu'bi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lindsay</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Harkin</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>McIntyre</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lisgo</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Clowry</surname>
<given-names>GJ</given-names>
</string-name> (<year>2017b</year>) <article-title>The transcription factors COUP‐TFI and COUP‐TFII have distinct roles in arealisation and GABAergic interneuron specification in the early human fetal telencephalon</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>27</volume>: <fpage>4971</fpage>–<lpage>4987</lpage>
<pub-id pub-id-type="pmid">28922831</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0007">
<mixed-citation id="embj2019104163-cit-0007" publication-type="journal">
<string-name>
<surname>Arai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pulvers</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Haffner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schilling</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Nüsslein</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Calegari</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name> (<year>2011</year>) <article-title>Neural stem and progenitor cells shorten S‐phase on commitment to neuron production</article-title>. <source xml:lang="en"/>Nat Commun
<volume>2</volume>: <fpage>154</fpage>
<pub-id pub-id-type="pmid">21224845</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0008">
<mixed-citation id="embj2019104163-cit-0008" publication-type="journal">
<string-name>
<surname>Armentano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Filosa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Andolfi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2006</year>) <article-title>COUP‐TFI is required for the formation of commissural projections in the forebrain by regulating axonal growth</article-title>. <source xml:lang="en"/>Development
<volume>133</volume>: <fpage>4151</fpage>–<lpage>4162</lpage>
<pub-id pub-id-type="pmid">17021036</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0009">
<mixed-citation id="embj2019104163-cit-0009" publication-type="journal">
<string-name>
<surname>Armentano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>S‐J</given-names>
</string-name>, <string-name>
<surname>Srubek Tomassy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Leingärtner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>O'Leary</surname>
<given-names>DDM</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2007</year>) <article-title>COUP‐TFI regulates the balance of cortical patterning between frontal/motor and sensory areas</article-title>. <source xml:lang="en"/>Nat Neurosci
<volume>10</volume>: <fpage>1277</fpage>–<lpage>1286</lpage>
<pub-id pub-id-type="pmid">17828260</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0010">
<mixed-citation id="embj2019104163-cit-0010" publication-type="journal">
<string-name>
<surname>Asami</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pilz</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Ninkovic</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Godinho</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Schroeder</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Gotz</surname>
<given-names>M</given-names>
</string-name> (<year>2011</year>) <article-title>The role of Pax6 in regulating the orientation and mode of cell division of progenitors in the mouse cerebral cortex</article-title>. <source xml:lang="en"/>Development
<volume>138</volume>: <fpage>5067</fpage>–<lpage>5078</lpage>
<pub-id pub-id-type="pmid">22031545</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0011">
<mixed-citation id="embj2019104163-cit-0011" publication-type="journal">
<string-name>
<surname>Barkovich</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kuzniecky</surname>
<given-names>RI</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</string-name> (<year>2012</year>) <article-title>A developmental and genetic classification for malformations of cortical development: update 2012</article-title>. <source xml:lang="en"/>Brain
<volume>135</volume>: <fpage>1348</fpage>–<lpage>1369</lpage>
<pub-id pub-id-type="pmid">22427329</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0012">
<mixed-citation id="embj2019104163-cit-0012" publication-type="journal">
<string-name>
<surname>Begemann</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Michon</surname>
<given-names>A‐M</given-names>
</string-name> (<year>1995</year>) <article-title>The <italic>Drosophila</italic> orphan nuclear receptor seven‐up requires the Ras pathway for its function in photoreceptor determination</article-title>. <source xml:lang="en"/>Development
<volume>121</volume>: <fpage>225</fpage>–<lpage>235</lpage>
<pub-id pub-id-type="pmid">7867504</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0013">
<mixed-citation id="embj2019104163-cit-0013" publication-type="journal">
<string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pandolfini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Murenu</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Viegi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Capsoni</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cellerino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Messina</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Casarosa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cremisi</surname>
<given-names>F</given-names>
</string-name> (<year>2013</year>) <article-title>The positional identity of mouse ES cell‐generated neurons is affected by BMP signaling</article-title>. <source xml:lang="en"/>Cell Mol Life Sci
<volume>70</volume>: <fpage>1095</fpage>–<lpage>1111</lpage>
<pub-id pub-id-type="pmid">23069989</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0014">
<mixed-citation id="embj2019104163-cit-0014" publication-type="journal">
<string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lupo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pandolfini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Casarosa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>D'Onofrio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pedersen</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Cremisi</surname>
<given-names>F</given-names>
</string-name> (<year>2015a</year>) <article-title>Activin/nodal signaling supports retinal progenitor specification in a narrow time window during pluripotent stem cell neuralization</article-title>. <source xml:lang="en"/>Stem Cell Rep
<volume>5</volume>: <fpage>532</fpage>–<lpage>545</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0015">
<mixed-citation id="embj2019104163-cit-0015" publication-type="journal">
<string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pandolfini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>D'Onofrio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brandi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cremisi</surname>
<given-names>F</given-names>
</string-name> (<year>2015b</year>) <article-title>The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells</article-title>. <source xml:lang="en"/>Dev Neurobiol
<volume>75</volume>: <fpage>66</fpage>–<lpage>79</lpage>
<pub-id pub-id-type="pmid">25044881</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0016">
<mixed-citation id="embj2019104163-cit-0016" publication-type="journal">
<string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Parisot</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2018</year>) <article-title>The pleiotropic transcriptional regulator COUP‐TFI plays multiple roles in neural development and disease</article-title>. <source xml:lang="en"/>Brain Res
<volume>1705</volume>: <fpage>75</fpage>–<lpage>94</lpage>
<pub-id pub-id-type="pmid">29709504</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0017">
<mixed-citation id="embj2019104163-cit-0017" publication-type="journal">
<string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gruart</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kaimakis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Allet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Serra</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Giacobini</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Delgado‐García</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Bovolenta</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2019</year>) <article-title>Mouse <italic>Nr2f1</italic> haploinsufficiency unveils new pathological mechanisms of a human optic atrophy syndrome</article-title>. <source xml:lang="en"/>EMBO Mol Med
<volume>11</volume>: <fpage>e10291</fpage>
<pub-id pub-id-type="pmid">31318166</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0018">
<mixed-citation id="embj2019104163-cit-0018" publication-type="journal">
<string-name>
<surname>Bishop</surname>
<given-names>KM</given-names>
</string-name> (<year>2000</year>) <article-title>Regulation of area identity in the mammalian neocortex by Emx2 and Pax6</article-title>. <source xml:lang="en"/>Science
<volume>288</volume>: <fpage>344</fpage>–<lpage>349</lpage>
<pub-id pub-id-type="pmid">10764649</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0019">
<mixed-citation id="embj2019104163-cit-0019" publication-type="journal">
<string-name>
<surname>Bishop</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</string-name>, <string-name>
<surname>O'Leary</surname>
<given-names>DDM</given-names>
</string-name> (<year>2002</year>) <article-title>Distinct actions of <italic>Emx1</italic>,<italic> Emx2</italic>, and <italic>Pax6</italic> in regulating the specification of areas in the developing neocortex</article-title>. <source xml:lang="en"/>J Neurosci
<volume>22</volume>: <fpage>7627</fpage>–<lpage>7638</lpage>
<pub-id pub-id-type="pmid">12196586</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0020">
<mixed-citation id="embj2019104163-cit-0020" publication-type="journal">
<string-name>
<surname>Bojanek</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Mosconi</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Guter</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Betancur</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Macmillan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cook</surname>
<given-names>EH</given-names>
</string-name> (<year>2019</year>) <article-title>Clinical and neurocognitive issues associated with Bosch‐Boonstra‐Schaaf optic atrophy syndrome: a case study</article-title>. <source xml:lang="en"/>Am J Med Genet A
<volume>182</volume>: <fpage>213</fpage>–<lpage>218</lpage>
<pub-id pub-id-type="pmid">31729143</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0021">
<mixed-citation id="embj2019104163-cit-0021" publication-type="journal">
<string-name>
<surname>Boland</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Clayton‐Smith</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>McKee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Manson</surname>
<given-names>FDC</given-names>
</string-name>, <string-name>
<surname>Medne</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zackai</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Swanson</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Fitzpatrick</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Millen</surname>
<given-names>KJ</given-names>
</string-name>
<italic>et al</italic> (<year>2007</year>) <article-title>Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum</article-title>. <source xml:lang="en"/>Am J Hum Genet
<volume>81</volume>: <fpage>292</fpage>–<lpage>303</lpage>
<pub-id pub-id-type="pmid">17668379</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0022">
<mixed-citation id="embj2019104163-cit-0022" publication-type="journal">
<string-name>
<surname>Bonzano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Crisci</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Podlesny‐Drabiniok</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rolando</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Krezel</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>De Marchis</surname>
<given-names>S</given-names>
</string-name> (<year>2018</year>) <article-title>Neuron‐astroglia cell fate decision in the adult mouse hippocampal neurogenic niche is cell‐intrinsically controlled by COUP‐TFI <italic>in vivo</italic>
</article-title>. <source xml:lang="en"/>Cell Rep
<volume>24</volume>: <fpage>329</fpage>–<lpage>341</lpage>
<pub-id pub-id-type="pmid">29996095</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0023">
<mixed-citation id="embj2019104163-cit-0023" publication-type="journal">
<string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Calegari</surname>
<given-names>F</given-names>
</string-name> (<year>2014</year>) <article-title>Mechanisms of brain evolution: regulation of neural progenitor cell diversity and cell cycle length</article-title>. <source xml:lang="en"/>Neurosci Res
<volume>86</volume>: <fpage>14</fpage>–<lpage>24</lpage>
<pub-id pub-id-type="pmid">24786671</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0024">
<mixed-citation id="embj2019104163-cit-0024" publication-type="journal">
<string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name> (<year>2018</year>) <article-title>How cells fold the cerebral cortex</article-title>. <source xml:lang="en"/>J Neurosci
<volume>38</volume>: <fpage>776</fpage>–<lpage>783</lpage>
<pub-id pub-id-type="pmid">29367288</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0025">
<mixed-citation id="embj2019104163-cit-0025" publication-type="journal">
<string-name>
<surname>Bosch</surname>
<given-names>DGM</given-names>
</string-name>, <string-name>
<surname>Boonstra</surname>
<given-names>FN</given-names>
</string-name>, <string-name>
<surname>Gonzaga‐Jauregui</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>de Ligt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jhangiani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wiszniewski</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Muzny</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Yntema</surname>
<given-names>HG</given-names>
</string-name>, <string-name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic> (<year>2014</year>) <article-title>NR2F1 mutations cause optic atrophy with intellectual disability</article-title>. <source xml:lang="en"/>Am J Hum Genet
<volume>94</volume>: <fpage>303</fpage>–<lpage>309</lpage>
<pub-id pub-id-type="pmid">24462372</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0026">
<mixed-citation id="embj2019104163-cit-0026" publication-type="journal">
<string-name>
<surname>Bovetti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bonzano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Garzotto</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Giannelli</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Iannielli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Armentano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>De Marchis</surname>
<given-names>S</given-names>
</string-name> (<year>2013</year>) <article-title>COUP‐TFI controls activity‐dependent tyrosine hydroxylase expression in adult dopaminergic olfactory bulb interneurons</article-title>. <source xml:lang="en"/>Development
<volume>140</volume>: <fpage>4850</fpage>–<lpage>4859</lpage>
<pub-id pub-id-type="pmid">24227652</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0027">
<mixed-citation id="embj2019104163-cit-0027" publication-type="journal">
<string-name>
<surname>Brewer</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Torricelli</surname>
<given-names>JR</given-names>
</string-name> (<year>2007</year>) <article-title>Isolation and culture of adult neurons and neurospheres</article-title>. <source xml:lang="en"/>Nat Protoc
<volume>2</volume>: <fpage>1490</fpage>–<lpage>1498</lpage>
<pub-id pub-id-type="pmid">17545985</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0028">
<mixed-citation id="embj2019104163-cit-0028" publication-type="journal">
<string-name>
<surname>Brown</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Alkuraya</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Matos</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Kimonis</surname>
<given-names>VE</given-names>
</string-name>, <string-name>
<surname>Morton</surname>
<given-names>CC</given-names>
</string-name> (<year>2009</year>) <article-title>NR2F1 deletion in a patient with a <italic>de novo</italic> paracentric inversion, inv(5)(q15q33.2), and syndromic deafness</article-title>. <source xml:lang="en"/>Am J Med Genet A
<volume>149A</volume>: <fpage>931</fpage>–<lpage>938</lpage>
<pub-id pub-id-type="pmid">19353646</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0029">
<mixed-citation id="embj2019104163-cit-0029" publication-type="journal">
<string-name>
<surname>Buttitta</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Edgar</surname>
<given-names>BA</given-names>
</string-name> (<year>2007</year>) <article-title>Mechanisms controlling cell cycle exit upon terminal differentiation</article-title>. <source xml:lang="en"/>Curr Opin Cell Biol
<volume>19</volume>: <fpage>697</fpage>–<lpage>704</lpage>
<pub-id pub-id-type="pmid">18035529</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0030">
<mixed-citation id="embj2019104163-cit-0030" publication-type="journal">
<string-name>
<surname>Cadwell</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Bhaduri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mostajo‐Radji</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Keefe</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Nowakowski</surname>
<given-names>TJ</given-names>
</string-name> (<year>2019</year>) <article-title>Development and arealization of the cerebral cortex</article-title>. <source xml:lang="en"/>Neuron
<volume>103</volume>: <fpage>980</fpage>–<lpage>1004</lpage>
<pub-id pub-id-type="pmid">31557462</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0031">
<mixed-citation id="embj2019104163-cit-0031" publication-type="journal">
<string-name>
<surname>Calegari</surname>
<given-names>F</given-names>
</string-name> (<year>2005</year>) <article-title>Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development</article-title>. <source xml:lang="en"/>J Neurosci
<volume>25</volume>: <fpage>6533</fpage>–<lpage>6538</lpage>
<pub-id pub-id-type="pmid">16014714</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0032">
<mixed-citation id="embj2019104163-cit-0032" publication-type="journal">
<string-name>
<surname>Cappello</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gray</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Badouel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lange</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Einsiedler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Srour</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chitayat</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>ZA</given-names>
</string-name>, <string-name>
<surname>Morgan</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Mutations in genes encoding the cadherin receptor‐ligand pair DCHS1 and FAT4 disrupt cerebral cortical development</article-title>. <source xml:lang="en"/>Nat Genet
<volume>45</volume>: <fpage>1300</fpage>–<lpage>1308</lpage>
<pub-id pub-id-type="pmid">24056717</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0033">
<mixed-citation id="embj2019104163-cit-0033" publication-type="journal">
<string-name>
<surname>Cárdenas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Villalba</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de Juan Romero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Picó</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kyrousi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tzika</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Tessier‐Lavigne</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Drukker</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cappello</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic> (<year>2018</year>) <article-title>Evolution of cortical neurogenesis in amniotes controlled by robo signaling levels</article-title>. <source xml:lang="en"/>Cell
<volume>174</volume>: <fpage>590</fpage>–<lpage>606.e21</lpage>
<pub-id pub-id-type="pmid">29961574</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0034">
<mixed-citation id="embj2019104163-cit-0034" publication-type="journal">
<string-name>
<surname>Cardoso</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Boys</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Parrini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mignon‐Ravix</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Khantane</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bertini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pallesi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Missirian</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zuffardi</surname>
<given-names>O</given-names>
</string-name>
<italic>et al</italic> (<year>2009</year>) <article-title>Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3‐q15 deletion</article-title>. <source xml:lang="en"/>Neurology
<volume>72</volume>: <fpage>784</fpage>–<lpage>792</lpage>
<pub-id pub-id-type="pmid">19073947</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0035">
<mixed-citation id="embj2019104163-cit-0035" publication-type="journal">
<string-name>
<surname>Caviness</surname>
<given-names>VS</given-names>
</string-name> (<year>2003</year>) <article-title>Cell output, cell cycle duration and neuronal specification: a model of integrated mechanisms of the neocortical proliferative process</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>13</volume>: <fpage>592</fpage>–<lpage>598</lpage>
<pub-id pub-id-type="pmid">12764033</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0036">
<mixed-citation id="embj2019104163-cit-0036" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>C‐A</given-names>
</string-name>, <string-name>
<surname>Bosch</surname>
<given-names>DGM</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Shinawi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Mann</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jayakar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Payne</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>L</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>The expanding clinical phenotype of Bosch‐Boonstra‐Schaaf optic atrophy syndrome: 20 new cases and possible genotype‐phenotype correlations</article-title>. <source xml:lang="en"/>Genet Med Off J Am Coll Med Genet
<volume>18</volume>: <fpage>1143</fpage>–<lpage>1150</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0037">
<mixed-citation id="embj2019104163-cit-0037" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>C‐A</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</string-name> (<year>2017</year>) <article-title>Genetic causes of optic nerve hypoplasia</article-title>. <source xml:lang="en"/>J Med Genet
<volume>54</volume>: <fpage>441</fpage>–<lpage>449</lpage>
<pub-id pub-id-type="pmid">28501829</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0038">
<mixed-citation id="embj2019104163-cit-0038" publication-type="journal">
<string-name>
<surname>Contestabile</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fila</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bartesaghi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ciani</surname>
<given-names>E</given-names>
</string-name> (<year>2009</year>) <article-title>Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for down syndrome</article-title>. <source xml:lang="en"/>Brain Pathol
<volume>19</volume>: <fpage>224</fpage>–<lpage>237</lpage>
<pub-id pub-id-type="pmid">18482164</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0039">
<mixed-citation id="embj2019104163-cit-0039" publication-type="journal">
<string-name>
<surname>Conti</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pollard</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Gorba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Reitano</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Toselli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Biella</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sanzone</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ying</surname>
<given-names>Q‐L</given-names>
</string-name>, <string-name>
<surname>Cattaneo</surname>
<given-names>E</given-names>
</string-name>
<italic>et al</italic> (<year>2005</year>) <article-title>Niche‐independent symmetrical self‐renewal of a mammalian tissue stem cell</article-title>. <source xml:lang="en"/>PLoS Biol
<volume>3</volume>: <fpage>e283</fpage>
<pub-id pub-id-type="pmid">16086633</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0040">
<mixed-citation id="embj2019104163-cit-0040" publication-type="journal">
<string-name>
<surname>Dehay</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>H</given-names>
</string-name> (<year>2007</year>) <article-title>Cell‐cycle control and cortical development</article-title>. <source xml:lang="en"/>Nat Rev Neurosci
<volume>8</volume>: <fpage>438</fpage>–<lpage>450</lpage>
<pub-id pub-id-type="pmid">17514197</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0041">
<mixed-citation id="embj2019104163-cit-0041" publication-type="journal">
<string-name>
<surname>Englund</surname>
<given-names>C</given-names>
</string-name> (<year>2005</year>) <article-title>Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex</article-title>. <source xml:lang="en"/>J Neurosci
<volume>25</volume>: <fpage>247</fpage>–<lpage>251</lpage>
<pub-id pub-id-type="pmid">15634788</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0042">
<mixed-citation id="embj2019104163-cit-0042" publication-type="journal">
<string-name>
<surname>Estivill‐Torrus</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pearson</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>van Heyningen</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Rashbass</surname>
<given-names>P</given-names>
</string-name> (<year>2002</year>) <article-title>Pax6 is required to regulate the cell cycle and the rate of progression from symmetrical to asymmetrical division in mammalian cortical progenitors</article-title>. <source xml:lang="en"/>Development
<volume>129</volume>: <fpage>455</fpage>–<lpage>466</lpage>
<pub-id pub-id-type="pmid">11807037</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0043">
<mixed-citation id="embj2019104163-cit-0043" publication-type="journal">
<string-name>
<surname>Faedo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tomassy</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Teichmann</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Krauss</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pleasure</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>M‐J</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</string-name> (<year>2008</year>) <article-title>COUP‐TFI coordinates cortical patterning, neurogenesis, and laminar fate and modulates MAPK/ERK, AKT, and β‐catenin signaling</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>18</volume>: <fpage>2117</fpage>–<lpage>2131</lpage>
<pub-id pub-id-type="pmid">18165280</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0044">
<mixed-citation id="embj2019104163-cit-0044" publication-type="journal">
<string-name>
<surname>Fernández</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Llinares‐Benadero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name> (<year>2016</year>) <article-title>Cerebral cortex expansion and folding: what have we learned?</article-title>
<source xml:lang="en"/>EMBO J
<volume>35</volume>: <fpage>1021</fpage>–<lpage>1044</lpage>
<pub-id pub-id-type="pmid">27056680</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0045">
<mixed-citation id="embj2019104163-cit-0045" publication-type="journal">
<collab collab-type="authors">Finding of Rare Disease Genes (FORGE) Canada Consortium</collab>
, <string-name>
<surname>Rivière</surname>
<given-names>J‐B</given-names>
</string-name>, <string-name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>O'Roak</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Beddaoui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alcantara</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Conway</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>St‐Onge</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schwartzentruber</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Gripp</surname>
<given-names>KW</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>
<italic>De novo</italic> germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes</article-title>. <source xml:lang="en"/>Nat Genet
<volume>44</volume>: <fpage>934</fpage>–<lpage>940</lpage>
<pub-id pub-id-type="pmid">22729224</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0046">
<mixed-citation id="embj2019104163-cit-0046" publication-type="journal">
<string-name>
<surname>Flore</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Di Ruberto</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Parisot</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sannino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Russo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Illingworth</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>De Leonibus</surname>
<given-names>E</given-names>
</string-name> (<year>2016</year>) <article-title>Gradient COUP‐TFI expression is required for functional organization of the hippocampal septo‐temporal longitudinal axis</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>27</volume>: <fpage>1629</fpage>–<lpage>1643</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0047">
<mixed-citation id="embj2019104163-cit-0047" publication-type="journal">
<string-name>
<surname>Florio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name> (<year>2014</year>) <article-title>Neural progenitors, neurogenesis and the evolution of the neocortex</article-title>. <source xml:lang="en"/>Development
<volume>141</volume>: <fpage>2182</fpage>–<lpage>2194</lpage>
<pub-id pub-id-type="pmid">24866113</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0048">
<mixed-citation id="embj2019104163-cit-0048" publication-type="journal">
<string-name>
<surname>Florio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Albert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Taverna</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Namba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Brandl</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lewitus</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Haffner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sykes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>FK</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Human‐specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion</article-title>. <source xml:lang="en"/>Science
<volume>347</volume>: <fpage>1465</fpage>–<lpage>1470</lpage>
<pub-id pub-id-type="pmid">25721503</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0049">
<mixed-citation id="embj2019104163-cit-0049" publication-type="journal">
<string-name>
<surname>Garcia‐Moreno</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vasistha</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Trevia</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bourne</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Molnar</surname>
<given-names>Z</given-names>
</string-name> (<year>2012</year>) <article-title>Compartmentalization of cerebral cortical germinal zones in a lissencephalic primate and gyrencephalic rodent</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>22</volume>: <fpage>482</fpage>–<lpage>492</lpage>
<pub-id pub-id-type="pmid">22114081</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0050">
<mixed-citation id="embj2019104163-cit-0050" publication-type="journal">
<string-name>
<surname>Georgala</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Manuel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>DJ</given-names>
</string-name> (<year>2011</year>) <article-title>The generation of superficial cortical layers is regulated by levels of the transcription factor Pax6</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>21</volume>: <fpage>81</fpage>–<lpage>94</lpage>
<pub-id pub-id-type="pmid">20413449</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0051">
<mixed-citation id="embj2019104163-cit-0051" publication-type="journal">
<string-name>
<surname>Glickstein</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Alexander</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>ME</given-names>
</string-name> (<year>2007</year>) <article-title>Differences in cyclin D2 and D1 protein expression distinguish forebrain progenitor subsets</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>17</volume>: <fpage>632</fpage>–<lpage>642</lpage>
<pub-id pub-id-type="pmid">16627858</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0052">
<mixed-citation id="embj2019104163-cit-0052" publication-type="miscellaneous">
<string-name>
<surname>Gompers</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Su‐Feher</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ellegood</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Stradleigh</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Zdilar</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Copping</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Pride</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Schaffler</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Riyadh</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Kaushik</surname>
<given-names>G</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>Heterozygous mutation to causes macrocephaly and widespread alteration of neurodevelopmental transcriptional networks in mouse</article-title>. <italic>bioRxiv</italic>
<pub-id pub-id-type="doi">10.1101/076158</pub-id> [PREPRINT]</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0053">
<mixed-citation id="embj2019104163-cit-0053" publication-type="journal">
<string-name>
<surname>Götz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name> (<year>2005</year>) <article-title>The cell biology of neurogenesis</article-title>. <source xml:lang="en"/>Nat Rev Mol Cell Biol
<volume>6</volume>: <fpage>777</fpage>–<lpage>788</lpage>
<pub-id pub-id-type="pmid">16314867</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0054">
<mixed-citation id="embj2019104163-cit-0054" publication-type="journal">
<string-name>
<surname>Groszer</surname>
<given-names>M</given-names>
</string-name> (<year>2001</year>) <article-title>Negative regulation of neural stem/progenitor cell proliferation by the pten tumor suppressor gene <italic>in vivo</italic>
</article-title>. <source xml:lang="en"/>Science
<volume>294</volume>: <fpage>2186</fpage>–<lpage>2189</lpage>
<pub-id pub-id-type="pmid">11691952</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0055">
<mixed-citation id="embj2019104163-cit-0055" publication-type="journal">
<string-name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</string-name> (<year>2014</year>) <article-title>Malformations of cortical development: clinical features and genetic causes</article-title>. <source xml:lang="en"/>Lancet Neurol
<volume>13</volume>: <fpage>710</fpage>–<lpage>726</lpage>
<pub-id pub-id-type="pmid">24932993</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0056">
<mixed-citation id="embj2019104163-cit-0056" publication-type="journal">
<string-name>
<surname>Hansen</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Lui</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>PRL</given-names>
</string-name>, <string-name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</string-name> (<year>2010</year>) <article-title>Neurogenic radial glia in the outer subventricular zone of human neocortex</article-title>. <source xml:lang="en"/>Nature
<volume>464</volume>: <fpage>554</fpage>–<lpage>561</lpage>
<pub-id pub-id-type="pmid">20154730</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0057">
<mixed-citation id="embj2019104163-cit-0057" publication-type="journal">
<string-name>
<surname>Heldring</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Joseph</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hermanson</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Kioussi</surname>
<given-names>C</given-names>
</string-name> (<year>2012</year>) <article-title>Pitx2 expression promotes p21 expression and cell cycle exit in neural stem cells</article-title>. <source xml:lang="en"/>CNS Neurol Disord Drug Target
<volume>11</volume>: <fpage>884</fpage>–<lpage>892</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0058">
<mixed-citation id="embj2019104163-cit-0058" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Sherman</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</string-name> (<year>2009</year>) <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source xml:lang="en"/>Nat Protoc
<volume>4</volume>: <fpage>44</fpage>–<lpage>57</lpage>
<pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0059">
<mixed-citation id="embj2019104163-cit-0059" publication-type="journal">
<string-name>
<surname>Jansen</surname>
<given-names>A</given-names>
</string-name> (<year>2005</year>) <article-title>Genetics of the polymicrogyria syndromes</article-title>. <source xml:lang="en"/>J Med Genet
<volume>42</volume>: <fpage>369</fpage>–<lpage>378</lpage>
<pub-id pub-id-type="pmid">15863665</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0060">
<mixed-citation id="embj2019104163-cit-0060" publication-type="journal">
<string-name>
<surname>Jiao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>ZG</given-names>
</string-name>, <string-name>
<surname>Hornyak</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Hozeska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Strickland</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Chopp</surname>
<given-names>M</given-names>
</string-name> (<year>2006</year>) <article-title>Dopachrome tautomerase (Dct) regulates neural progenitor cell proliferation</article-title>. <source xml:lang="en"/>Dev Biol
<volume>296</volume>: <fpage>396</fpage>–<lpage>408</lpage>
<pub-id pub-id-type="pmid">16857183</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0061">
<mixed-citation id="embj2019104163-cit-0061" publication-type="journal">
<string-name>
<surname>de Juan Romero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bruder</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tomasello</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Sanz‐Anquela</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name> (<year>2015</year>) <article-title>Discrete domains of gene expression in germinal layers distinguish the development of gyrencephaly</article-title>. <source xml:lang="en"/>EMBO J
<volume>34</volume>: <fpage>1859</fpage>–<lpage>1874</lpage>
<pub-id pub-id-type="pmid">25916825</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0062">
<mixed-citation id="embj2019104163-cit-0062" publication-type="journal">
<string-name>
<surname>Juric‐Sekhar</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hevner</surname>
<given-names>RF</given-names>
</string-name> (<year>2019</year>) <article-title>Malformations of cerebral cortex development: molecules and mechanisms</article-title>. <source xml:lang="en"/>Annu Rev Pathol Mech Dis
<volume>14</volume>: <fpage>293</fpage>–<lpage>318</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0063">
<mixed-citation id="embj2019104163-cit-0063" publication-type="journal">
<string-name>
<surname>Kaiwar</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zimmermann</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Ferber</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Urrutia</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Klee</surname>
<given-names>EW</given-names>
</string-name>, <string-name>
<surname>Babovic‐Vuksanovic</surname>
<given-names>D</given-names>
</string-name> (<year>2017</year>) <article-title>Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype‐phenotype correlation, and phenotypic expansion of the Bosch‐Boonstra‐Schaaf optic atrophy syndrome</article-title>. <source xml:lang="en"/>Cold Spring Harb Mol Case Stud
<volume>3</volume>: <fpage>a002162</fpage>
<pub-id pub-id-type="pmid">28963436</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0065">
<mixed-citation id="embj2019104163-cit-0065" publication-type="journal">
<string-name>
<surname>Kelava</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Reillo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Murayama</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Kalinka</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Stenzel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tomancak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Matsuzaki</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lebrand</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schwamborn</surname>
<given-names>JC</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Abundant occurrence of basal radial glia in the subventricular zone of embryonic neocortex of a lissencephalic primate, the common marmoset callithrix jacchus</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>22</volume>: <fpage>469</fpage>–<lpage>481</lpage>
<pub-id pub-id-type="pmid">22114084</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0066">
<mixed-citation id="embj2019104163-cit-0066" publication-type="journal">
<string-name>
<surname>Klaus</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kanton</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kyrousi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ayo‐Martin</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Di Giaimo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Riesenberg</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>O'Neill</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Camp</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Tocco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Santel</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic> (<year>2019</year>) <article-title>Altered neuronal migratory trajectories in human cerebral organoids derived from individuals with neuronal heterotopia</article-title>. <source xml:lang="en"/>Nat Med
<volume>25</volume>: <fpage>561</fpage>–<lpage>568</lpage>
<pub-id pub-id-type="pmid">30858616</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0067">
<mixed-citation id="embj2019104163-cit-0067" publication-type="journal">
<string-name>
<surname>Kostović</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sedmak</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Judaš</surname>
<given-names>M</given-names>
</string-name> (<year>2019</year>) <article-title>Neural histology and neurogenesis of the human fetal and infant brain</article-title>. <source xml:lang="en"/>NeuroImage
<volume>188</volume>: <fpage>743</fpage>–<lpage>773</lpage>
<pub-id pub-id-type="pmid">30594683</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0068">
<mixed-citation id="embj2019104163-cit-0068" publication-type="journal">
<string-name>
<surname>Kostovic</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Vasung</surname>
<given-names>L</given-names>
</string-name> (<year>2009</year>) <article-title>Insights from <italic>in vitro</italic> fetal magnetic resonance imaging of cerebral development</article-title>. <source xml:lang="en"/>Semin Perinatol
<volume>33</volume>: <fpage>220</fpage>–<lpage>233</lpage>
<pub-id pub-id-type="pmid">19631083</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0069">
<mixed-citation id="embj2019104163-cit-0069" publication-type="journal">
<string-name>
<surname>Kumamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hanashima</surname>
<given-names>C</given-names>
</string-name> (<year>2014</year>) <article-title>Neuronal subtype specification in establishing mammalian neocortical circuits</article-title>. <source xml:lang="en"/>Neurosci Res
<volume>86</volume>: <fpage>37</fpage>–<lpage>49</lpage>
<pub-id pub-id-type="pmid">25019611</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0070">
<mixed-citation id="embj2019104163-cit-0070" publication-type="journal">
<string-name>
<surname>Kwon</surname>
<given-names>C‐H</given-names>
</string-name>, <string-name>
<surname>Luikart</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Powell</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Matheny</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Parada</surname>
<given-names>LF</given-names>
</string-name> (<year>2006</year>) <article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>. <source xml:lang="en"/>Neuron
<volume>50</volume>: <fpage>377</fpage>–<lpage>388</lpage>
<pub-id pub-id-type="pmid">16675393</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0071">
<mixed-citation id="embj2019104163-cit-0071" publication-type="journal">
<string-name>
<surname>LaMonica</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Lui</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</string-name> (<year>2013</year>) <article-title>Mitotic spindle orientation predicts outer radial glial cell generation in human neocortex</article-title>. <source xml:lang="en"/>Nat Commun
<volume>4</volume>: <fpage>1665</fpage>
<pub-id pub-id-type="pmid">23575669</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0072">
<mixed-citation id="embj2019104163-cit-0072" publication-type="journal">
<string-name>
<surname>Lancaster</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Renner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>C‐A</given-names>
</string-name>, <string-name>
<surname>Wenzel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bicknell</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Hurles</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Homfray</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Penninger</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Knoblich</surname>
<given-names>JA</given-names>
</string-name> (<year>2013</year>) <article-title>Cerebral organoids model human brain development and microcephaly</article-title>. <source xml:lang="en"/>Nature
<volume>501</volume>: <fpage>373</fpage>–<lpage>379</lpage>
<pub-id pub-id-type="pmid">23995685</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0073">
<mixed-citation id="embj2019104163-cit-0073" publication-type="journal">
<string-name>
<surname>Lange</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Calegari</surname>
<given-names>F</given-names>
</string-name> (<year>2009</year>) <article-title>Cdk4/CyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors</article-title>. <source xml:lang="en"/>Cell Stem Cell
<volume>5</volume>: <fpage>320</fpage>–<lpage>331</lpage>
<pub-id pub-id-type="pmid">19733543</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0074">
<mixed-citation id="embj2019104163-cit-0074" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Huynh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Silhavy</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dixon‐Salazar</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Heiberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bafna</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Collazo</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>
<italic>De novo</italic> somatic mutations in components of the PI3K‐AKT3‐mTOR pathway cause hemimegalencephaly</article-title>. <source xml:lang="en"/>Nat Genet
<volume>44</volume>: <fpage>941</fpage>–<lpage>945</lpage>
<pub-id pub-id-type="pmid">22729223</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0075">
<mixed-citation id="embj2019104163-cit-0075" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Muffat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Omer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bosch</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Lancaster</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Sur</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gehrke</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Knoblich</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name> (<year>2017</year>) <article-title>Induction of expansion and folding in human cerebral organoids</article-title>. <source xml:lang="en"/>Cell Stem Cell
<volume>20</volume>: <fpage>385</fpage>–<lpage>396.e3</lpage>
<pub-id pub-id-type="pmid">28041895</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0076">
<mixed-citation id="embj2019104163-cit-0076" publication-type="journal">
<string-name>
<surname>Lodato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tomassy</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>De Leonibus</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Uzcategui</surname>
<given-names>YG</given-names>
</string-name>, <string-name>
<surname>Andolfi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Armentano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Touzot</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gaztelu</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Arlotta</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Menendez de la Prida</surname>
<given-names>L</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Loss of COUP‐TFI alters the balance between caudal ganglionic eminence‐ and medial ganglionic eminence‐derived cortical interneurons and results in resistance to epilepsy</article-title>. <source xml:lang="en"/>J Neurosci
<volume>31</volume>: <fpage>4650</fpage>–<lpage>4662</lpage>
<pub-id pub-id-type="pmid">21430164</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0077">
<mixed-citation id="embj2019104163-cit-0077" publication-type="journal">
<string-name>
<surname>Love</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Huber</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Anders</surname>
<given-names>S</given-names>
</string-name> (<year>2014</year>) <article-title>Moderated estimation of fold change and dispersion for RNA‐seq data with DESeq2</article-title>. <source xml:lang="en"/>Genome Biol
<volume>15</volume>: <fpage>550</fpage>
<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0500">
<mixed-citation id="embj2019104163-cit-0500" publication-type="journal">
<string-name>
<surname>Lukaszewicz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Savatier</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cortay</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Giroud</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Huissoud</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Berland</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Dehay</surname>
<given-names>C</given-names>
</string-name> (<year>2005</year>) <article-title>G1 phase regulation, area‐specific cell cycle control, and cytoarchitectonics in the primate cortex</article-title>. <source xml:lang="en"/>Neuron
<volume>47</volume>: <fpage>353</fpage>–<lpage>364</lpage>
<pub-id pub-id-type="pmid">16055060</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0078">
<mixed-citation id="embj2019104163-cit-0078" publication-type="journal">
<string-name>
<surname>Lykke‐Andersen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>TH</given-names>
</string-name> (<year>2015</year>) <article-title>Nonsense‐mediated mRNA decay: an intricate machinery that shapes transcriptomes</article-title>. <source xml:lang="en"/>Nat Rev Mol Cell Biol
<volume>16</volume>: <fpage>665</fpage>–<lpage>677</lpage>
<pub-id pub-id-type="pmid">26397022</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0079">
<mixed-citation id="embj2019104163-cit-0079" publication-type="journal">
<string-name>
<surname>Manzini</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</string-name> (<year>2011</year>) <article-title>What disorders of cortical development tell us about the cortex: one plus one does not always make two</article-title>. <source xml:lang="en"/>Curr Opin Genet Dev
<volume>21</volume>: <fpage>333</fpage>–<lpage>339</lpage>
<pub-id pub-id-type="pmid">21288712</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0080">
<mixed-citation id="embj2019104163-cit-0080" publication-type="journal">
<string-name>
<surname>Marchese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Conti</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Valvo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Moro</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Muratori</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tancredi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Santorelli</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sicca</surname>
<given-names>F</given-names>
</string-name> (<year>2014</year>) <article-title>Autism‐epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening</article-title>. <source xml:lang="en"/>BMC Med Genet
<volume>15</volume>: <fpage>26</fpage>
<pub-id pub-id-type="pmid">24580998</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0081">
<mixed-citation id="embj2019104163-cit-0081" publication-type="journal">
<string-name>
<surname>Martín‐Hernández</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rodríguez‐García</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C‐A</given-names>
</string-name>, <string-name>
<surname>Cotrina‐Vinagre</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Carnicero‐Rodríguez</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bellusci</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Martínez‐Azorín</surname>
<given-names>F</given-names>
</string-name> (<year>2018</year>) <article-title>Mitochondrial involvement in a Bosch‐Boonstra‐Schaaf optic atrophy syndrome patient with a novel <italic>de novo</italic> NR2F1 gene mutation</article-title>. <source xml:lang="en"/>J Hum Genet
<volume>63</volume>: <fpage>525</fpage>–<lpage>528</lpage>
<pub-id pub-id-type="pmid">29410510</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0082">
<mixed-citation id="embj2019104163-cit-0082" publication-type="journal">
<string-name>
<surname>Martynoga</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Morrison</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Mason</surname>
<given-names>JO</given-names>
</string-name> (<year>2005</year>) <article-title>Foxg1 is required for specification of ventral telencephalon and region‐specific regulation of dorsal telencephalic precursor proliferation and apoptosis</article-title>. <source xml:lang="en"/>Dev Biol
<volume>283</volume>: <fpage>113</fpage>–<lpage>127</lpage>
<pub-id pub-id-type="pmid">15893304</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0083">
<mixed-citation id="embj2019104163-cit-0083" publication-type="journal">
<string-name>
<surname>Matsuzaki</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shitamukai</surname>
<given-names>A</given-names>
</string-name> (<year>2015</year>) <article-title>Cell division modes and cleavage planes of neural progenitors during mammalian cortical development</article-title>. <source xml:lang="en"/>Cold Spring Harb. Perspect. Biol.
<volume>7</volume>: <fpage>a015719</fpage>
<pub-id pub-id-type="pmid">26330517</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0084">
<mixed-citation id="embj2019104163-cit-0084" publication-type="journal">
<string-name>
<surname>Mi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Carr</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>Georgala</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y‐T</given-names>
</string-name>, <string-name>
<surname>Manuel</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Jeanes</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Niisato</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sansom</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Livesey</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Theil</surname>
<given-names>T</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Pax6 exerts regional control of cortical progenitor proliferation via direct repression of Cdk6 and hypophosphorylation of pRb</article-title>. <source xml:lang="en"/>Neuron
<volume>78</volume>: <fpage>269</fpage>–<lpage>284</lpage>
<pub-id pub-id-type="pmid">23622063</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0085">
<mixed-citation id="embj2019104163-cit-0085" publication-type="journal">
<string-name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>RivièRe</surname>
<given-names>J‐B</given-names>
</string-name>, <string-name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</string-name> (<year>2013</year>) <article-title>Megalencephaly syndromes and activating mutations in the PI3K‐AKT pathway: MPPH and MCAP</article-title>. <source xml:lang="en"/>Am J Med Genet C Semin Med Genet
<volume>163</volume>: <fpage>122</fpage>–<lpage>130</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0086">
<mixed-citation id="embj2019104163-cit-0086" publication-type="journal">
<string-name>
<surname>Noctor</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Martínez‐Cerdeño</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</string-name> (<year>2008</year>) <article-title>Distinct behaviors of neural stem and progenitor cells underlie cortical neurogenesis</article-title>. <source xml:lang="en"/>J Comp Neurol
<volume>508</volume>: <fpage>28</fpage>–<lpage>44</lpage>
<pub-id pub-id-type="pmid">18288691</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0087">
<mixed-citation id="embj2019104163-cit-0087" publication-type="journal">
<string-name>
<surname>Nonaka‐Kinoshita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Reillo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Artegiani</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ángeles Martínez‐Martínez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Calegari</surname>
<given-names>F</given-names>
</string-name> (<year>2013</year>) <article-title>Regulation of cerebral cortex size and folding by expansion of basal progenitors</article-title>. <source xml:lang="en"/>EMBO J
<volume>32</volume>: <fpage>1817</fpage>–<lpage>1828</lpage>
<pub-id pub-id-type="pmid">23624932</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0088">
<mixed-citation id="embj2019104163-cit-0088" publication-type="journal">
<string-name>
<surname>Nowakowski</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Lewin</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>MW</given-names>
</string-name> (<year>1989</year>) <article-title>Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA‐synthetic phase for an anatomically defined population</article-title>. <source xml:lang="en"/>J Neurocytol
<volume>18</volume>: <fpage>311</fpage>–<lpage>318</lpage>
<pub-id pub-id-type="pmid">2746304</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0089">
<mixed-citation id="embj2019104163-cit-0089" publication-type="journal">
<string-name>
<surname>Oberhuber</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hope</surname>
<given-names>TMH</given-names>
</string-name>, <string-name>
<surname>Seghier</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Parker Jones</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Prejawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>CJ</given-names>
</string-name> (<year>2016</year>) <article-title>Four functionally distinct regions in the left supramarginal gyrus support word processing</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>26</volume>: <fpage>4212</fpage>–<lpage>4226</lpage>
<pub-id pub-id-type="pmid">27600852</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0090">
<mixed-citation id="embj2019104163-cit-0090" publication-type="journal">
<collab collab-type="authors">Orphanomix Physicians’ Group</collab>
, <string-name>
<surname>Nambot</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Thevenon</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuentz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Duffourd</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tisserant</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bruel</surname>
<given-names>A‐L</given-names>
</string-name>, <string-name>
<surname>Mosca‐Boidron</surname>
<given-names>A‐L</given-names>
</string-name>, <string-name>
<surname>Masurel‐Paulet</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lehalle</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic> (<year>2018</year>) <article-title>Clinical whole‐exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis</article-title>. <source xml:lang="en"/>Genet Med
<volume>20</volume>: <fpage>645</fpage>–<lpage>654</lpage>
<pub-id pub-id-type="pmid">29095811</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0091">
<mixed-citation id="embj2019104163-cit-0091" publication-type="journal">
<string-name>
<surname>Parisot</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Flore</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2017</year>) <article-title>COUP‐TFI mitotically regulates production and migration of dentate granule cells and modulates hippocampal Cxcr4 expression</article-title>. <source xml:lang="en"/>Development
<volume>144</volume>: <fpage>2045</fpage>–<lpage>2058</lpage>
<pub-id pub-id-type="pmid">28506990</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0092">
<mixed-citation id="embj2019104163-cit-0092" publication-type="journal">
<string-name>
<surname>Park</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S‐T</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>S‐H</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>J</given-names>
</string-name> (<year>2019</year>) <article-title>Targeted panel sequencing identifies a novel <italic>NR2F1</italic> mutations in a patient with Bosch–Boonstra–Schaaf optic atrophy syndrome</article-title>. <source xml:lang="en"/>Ophthalmic Genet
<volume>40</volume>: <fpage>359</fpage>–<lpage>361</lpage>
<pub-id pub-id-type="pmid">31393201</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0093">
<mixed-citation id="embj2019104163-cit-0093" publication-type="journal">
<string-name>
<surname>Parrini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Conti</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Dobyns</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</string-name> (<year>2016</year>) <article-title>Genetic basis of brain malformations</article-title>. <source xml:lang="en"/>Mol Syndromol
<volume>7</volume>: <fpage>220</fpage>–<lpage>233</lpage>
<pub-id pub-id-type="pmid">27781032</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0094">
<mixed-citation id="embj2019104163-cit-0094" publication-type="journal">
<string-name>
<surname>Poduri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Elhosary</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Beroukhim</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lehtinen</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Hills</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Heinzen</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>RS</given-names>
</string-name>
<italic>et al</italic> (<year>2012</year>) <article-title>Somatic activation of AKT3 causes hemispheric developmental brain malformations</article-title>. <source xml:lang="en"/>Neuron
<volume>74</volume>: <fpage>41</fpage>–<lpage>48</lpage>
<pub-id pub-id-type="pmid">22500628</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0095">
<mixed-citation id="embj2019104163-cit-0095" publication-type="journal">
<string-name>
<surname>Pollen</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Nowakowski</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Retallack</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sandoval‐Espinosa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nicholas</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Shuga</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Oldham</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Diaz</surname>
<given-names>A</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Molecular identity of human outer radial glia during cortical development</article-title>. <source xml:lang="en"/>Cell
<volume>163</volume>: <fpage>55</fpage>–<lpage>67</lpage>
<pub-id pub-id-type="pmid">26406371</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0096">
<mixed-citation id="embj2019104163-cit-0096" publication-type="journal">
<string-name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cooney</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Kuratani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>DeMayo</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>MJ</given-names>
</string-name> (<year>1994</year>) <article-title>Spatiotemporal expression patterns of chicken ovalbumin upstream promoter‐transcription factors in the developing mouse central nervous system: evidence for a role in segmental patterning of the diencephalon</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<volume>91</volume>: <fpage>4451</fpage>–<lpage>4455</lpage>
<pub-id pub-id-type="pmid">8183930</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0097">
<mixed-citation id="embj2019104163-cit-0097" publication-type="journal">
<string-name>
<surname>Ran</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Agarwala</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>F</given-names>
</string-name> (<year>2013</year>) <article-title>Genome engineering using the CRISPR‐Cas9 system</article-title>. <source xml:lang="en"/>Nat Protoc
<volume>8</volume>: <fpage>2281</fpage>–<lpage>2308</lpage>
<pub-id pub-id-type="pmid">24157548</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0501">
<mixed-citation id="embj2019104163-cit-0501" publication-type="journal">
<string-name>
<surname>Rech</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Edmond</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Shah</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Bosch</surname>
<given-names>DGM</given-names>
</string-name>, <string-name>
<surname>Berry</surname>
<given-names>TG</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Madan‐Khetarpal</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Niyazov</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic> (<year>2020</year>) <article-title>Phenotypic expansion of Bosch–Boonstra–Schaaf optic atrophy syndrome and further evidence for genotype–phenotype correlations</article-title>. <source xml:lang="en"/>Am J Med Genet. <pub-id pub-id-type="doi">10.1002/ajmg.a.61580</pub-id>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0098">
<mixed-citation id="embj2019104163-cit-0098" publication-type="journal">
<string-name>
<surname>Reillo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>de Juan Romero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>García‐Cabezas</surname>
<given-names>MÁ</given-names>
</string-name>, <string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name> (<year>2011</year>) <article-title>A role for intermediate radial glia in the tangential expansion of the mammalian cerebral cortex</article-title>. <source xml:lang="en"/>Cereb Cortex
<volume>21</volume>: <fpage>1674</fpage>–<lpage>1694</lpage>
<pub-id pub-id-type="pmid">21127018</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0099">
<mixed-citation id="embj2019104163-cit-0099" publication-type="journal">
<string-name>
<surname>Reynolds</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Fraser</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Weiss</surname>
<given-names>S</given-names>
</string-name> (<year>1993</year>) <article-title>bFCF regulates the proliferative fate of unipotent (Neuronal) and bipotent (NeuronallAstroglial) EGF‐generated CNS progenitor cells</article-title>. <source xml:lang="en"/>Neuron
<volume>11</volume>: <fpage>951</fpage>–<lpage>966</lpage>
<pub-id pub-id-type="pmid">8240816</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0100">
<mixed-citation id="embj2019104163-cit-0100" publication-type="journal">
<string-name>
<surname>Saade</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gutiérrez‐Vallejo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Le Dréau</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rabadán</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Miguez</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Buceta</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Martí</surname>
<given-names>E</given-names>
</string-name> (<year>2013</year>) <article-title>Sonic hedgehog signaling switches the mode of division in the developing nervous system</article-title>. <source xml:lang="en"/>Cell Rep
<volume>4</volume>: <fpage>492</fpage>–<lpage>503</lpage>
<pub-id pub-id-type="pmid">23891002</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0101">
<mixed-citation id="embj2019104163-cit-0101" publication-type="journal">
<string-name>
<surname>Sansom</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Griffiths</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Faedo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kleinjan</surname>
<given-names>D‐J</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>van Heyningen</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Livesey</surname>
<given-names>FJ</given-names>
</string-name> (<year>2009</year>) <article-title>The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self‐renewal and neurogenesis</article-title>. <source xml:lang="en"/>PLoS Genet
<volume>5</volume>: <fpage>e1000511</fpage>
<pub-id pub-id-type="pmid">19521500</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0102">
<mixed-citation id="embj2019104163-cit-0102" publication-type="journal">
<string-name>
<surname>Sarnat</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Flores‐Sarnat</surname>
<given-names>L</given-names>
</string-name> (<year>2016</year>) <article-title>Telencephalic flexure and malformations of the lateral cerebral (Sylvian) fissure</article-title>. <source xml:lang="en"/>Pediatr Neurol
<volume>63</volume>: <fpage>23</fpage>–<lpage>38</lpage>
<pub-id pub-id-type="pmid">27590993</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0103">
<mixed-citation id="embj2019104163-cit-0103" publication-type="journal">
<string-name>
<surname>Siegenthaler</surname>
<given-names>JA</given-names>
</string-name> (<year>2005</year>) <article-title>Transforming growth factor 1 promotes cell cycle exit through the cyclin‐dependent kinase inhibitor p21 in the developing cerebral cortex</article-title>. <source xml:lang="en"/>J Neurosci
<volume>25</volume>: <fpage>8627</fpage>–<lpage>8636</lpage>
<pub-id pub-id-type="pmid">16177030</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0104">
<mixed-citation id="embj2019104163-cit-0104" publication-type="journal">
<string-name>
<surname>Stahl</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Walcher</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>De Juan Romero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pilz</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Cappello</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Irmler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sanz‐Aquela</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Beckers</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Blum</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name>
<italic>et al</italic> (<year>2013</year>) <article-title>Trnp1 regulates expansion and folding of the mammalian cerebral cortex by control of radial glial fate</article-title>. <source xml:lang="en"/>Cell
<volume>153</volume>: <fpage>535</fpage>–<lpage>549</lpage>
<pub-id pub-id-type="pmid">23622239</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0105">
<mixed-citation id="embj2019104163-cit-0105" publication-type="journal">
<string-name>
<surname>Stoeckel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gough</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Watkins</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Devlin</surname>
<given-names>JT</given-names>
</string-name> (<year>2009</year>) <article-title>Supramarginal gyrus involvement in visual word recognition</article-title>. <source xml:lang="en"/>Cortex
<volume>45</volume>: <fpage>1091</fpage>–<lpage>1096</lpage>
<pub-id pub-id-type="pmid">19232583</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0106">
<mixed-citation id="embj2019104163-cit-0106" publication-type="journal">
<string-name>
<surname>St‐Onge</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sosa‐Pineda</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chowdhury</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mansouri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gruss</surname>
<given-names>P</given-names>
</string-name> (<year>1997</year>) <article-title>Pax6 is required for differentiation of glucagon‐producing a‐cells in mouse pancreas</article-title>. <source xml:lang="en"/>Nature
<volume>387</volume>: <fpage>406</fpage>–<lpage>409</lpage>
<pub-id pub-id-type="pmid">9163426</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0107">
<mixed-citation id="embj2019104163-cit-0107" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hevner</surname>
<given-names>RF</given-names>
</string-name> (<year>2014</year>) <article-title>Growth and folding of the mammalian cerebral cortex: from molecules to malformations</article-title>. <source xml:lang="en"/>Nat Rev Neurosci
<volume>15</volume>: <fpage>217</fpage>–<lpage>232</lpage>
<pub-id pub-id-type="pmid">24646670</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0108">
<mixed-citation id="embj2019104163-cit-0108" publication-type="journal">
<string-name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nowakowski</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Caviness</surname>
<given-names>V</given-names>
</string-name> (<year>1993</year>) <article-title>Cell cycle parameters and patterns of nuclear movement in the neocortical proliferative zone of the fetal mouse</article-title>. <source xml:lang="en"/>J Neurosci
<volume>13</volume>: <fpage>820</fpage>–<lpage>833</lpage>
<pub-id pub-id-type="pmid">8426239</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0109">
<mixed-citation id="embj2019104163-cit-0109" publication-type="journal">
<string-name>
<surname>Tang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>J‐I</given-names>
</string-name>, <string-name>
<surname>Jamrich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>M‐J</given-names>
</string-name> (<year>2010</year>) <article-title>COUP‐TFs regulate eye development by controlling factors essential for optic vesicle morphogenesis</article-title>. <source xml:lang="en"/>Development
<volume>137</volume>: <fpage>725</fpage>–<lpage>734</lpage>
<pub-id pub-id-type="pmid">20147377</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0110">
<mixed-citation id="embj2019104163-cit-0110" publication-type="journal">
<string-name>
<surname>Terrigno</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bertacchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pandolfini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Baumgart</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Calvello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cellerino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cremisi</surname>
<given-names>F</given-names>
</string-name> (<year>2018</year>) <article-title>The microRNA miR‐21 is a mediator of FGF8 action on cortical COUP‐TFI translation</article-title>. <source xml:lang="en"/>Stem Cell Rep
<volume>11</volume>: <fpage>756</fpage>–<lpage>769</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0111">
<mixed-citation id="embj2019104163-cit-0111" publication-type="journal">
<string-name>
<surname>Terrone</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Voisin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Abdullah Alfaiz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cappuccio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vitiello</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Guex</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>D'Amico</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>James Barkovich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brunetti‐Pierri</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Del Giudice</surname>
<given-names>E</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>
<italic>De novo</italic> PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia</article-title>. <source xml:lang="en"/>Eur J Hum Genet
<volume>24</volume>: <fpage>1359</fpage>–<lpage>1362</lpage>
<pub-id pub-id-type="pmid">26860062</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0112">
<mixed-citation id="embj2019104163-cit-0112" publication-type="journal">
<string-name>
<surname>Tokuda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mahaffey</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Monks</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Faulkner</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Birnbaum</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Danzer</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Frankel</surname>
<given-names>WN</given-names>
</string-name> (<year>2011</year>) <article-title>A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice</article-title>. <source xml:lang="en"/>Hum Mol Genet
<volume>20</volume>: <fpage>988</fpage>–<lpage>999</lpage>
<pub-id pub-id-type="pmid">21159799</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0113">
<mixed-citation id="embj2019104163-cit-0113" publication-type="journal">
<string-name>
<surname>Tomassy</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>De Leonibus</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jabaudon</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lodato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Alfano</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mele</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Macklis</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>) <article-title>Area‐specific temporal control of corticospinal motor neuron differentiation by COUP‐TFI</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<volume>107</volume>: <fpage>3576</fpage>–<lpage>3581</lpage>
<pub-id pub-id-type="pmid">20133588</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0114">
<mixed-citation id="embj2019104163-cit-0114" publication-type="journal">
<string-name>
<surname>del Toro</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ruff</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Cederfjäll</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Villalba</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Seyit‐Bremer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Borrell</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Klein</surname> <given-names>R</given-names>
</string-name> (<year>2017</year>) <article-title>Regulation of cerebral cortex folding by controlling neuronal migration via FLRT adhesion molecules</article-title>. <source xml:lang="en"/>Cell
<volume>169</volume>: <fpage>621</fpage>–<lpage>635.e16</lpage>
<pub-id pub-id-type="pmid">28475893</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0115">
<mixed-citation id="embj2019104163-cit-0115" publication-type="journal">
<string-name>
<surname>Uzquiano</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cifuentes‐Diaz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jabali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Romero</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Houllier</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dingli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Maillard</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Boland</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Deleuze</surname>
<given-names>J‐F</given-names>
</string-name>, <string-name>
<surname>Loew</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic> (<year>2019</year>) <article-title>Mutations in the heterotopia gene Eml1/EML1 severely disrupt the formation of primary cilia</article-title>. <source xml:lang="en"/>Cell Rep
<volume>28</volume>: <fpage>1596</fpage>–<lpage>1611.e10</lpage>
<pub-id pub-id-type="pmid">31390572</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0116">
<mixed-citation id="embj2019104163-cit-0116" publication-type="journal">
<string-name>
<surname>Vaid</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Camp</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Hersemann</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Eugster Oegema</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Heninger</surname>
<given-names>A‐K</given-names>
</string-name>, <string-name>
<surname>Winkler</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brandl</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sarov</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Treutlein</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name>
<italic>et al</italic> (<year>2018</year>) <article-title>A novel population of Hopx‐dependent basal radial glial cells in the developing mouse neocortex</article-title>. <source xml:lang="en"/>Development
<volume>145</volume>: <fpage>dev169276</fpage>
<pub-id pub-id-type="pmid">30266827</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0117">
<mixed-citation id="embj2019104163-cit-0117" publication-type="journal">
<string-name>
<surname>Vasung</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lepage</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Radoš</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pletikos</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goldman</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Richiardi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Raguž</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fischi‐Gómez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Karama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huppi</surname>
<given-names>PS</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>Quantitative and qualitative analysis of transient fetal compartments during prenatal human brain development</article-title>. <source xml:lang="en"/>Front Neuroanat
<volume>10</volume>: <fpage>11</fpage>
<pub-id pub-id-type="pmid">26941612</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0118">
<mixed-citation id="embj2019104163-cit-0118" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>J‐W</given-names>
</string-name>, <string-name>
<surname>LaMonica</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</string-name> (<year>2011</year>) <article-title>A new subtype of progenitor cell in the mouse embryonic neocortex</article-title>. <source xml:lang="en"/>Nat Neurosci
<volume>14</volume>: <fpage>555</fpage>–<lpage>561</lpage>
<pub-id pub-id-type="pmid">21478886</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0119">
<mixed-citation id="embj2019104163-cit-0119" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name> (<year>2018</year>) <article-title>Modeling neurological diseases with human brain organoids</article-title>. <source xml:lang="en"/>Front Synaptic Neurosci
<volume>10</volume>: <fpage>15</fpage>
<pub-id pub-id-type="pmid">29937727</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0120">
<mixed-citation id="embj2019104163-cit-0120" publication-type="journal">
<string-name>
<surname>Wong</surname>
<given-names>FK</given-names>
</string-name>, <string-name>
<surname>Fei</surname>
<given-names>J‐F</given-names>
</string-name>, <string-name>
<surname>Mora‐Bermúdez</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Taverna</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Haffner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Anastassiadis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</string-name> (<year>2015</year>) <article-title>Sustained Pax6 expression generates primate‐like basal radial glia in developing mouse neocortex</article-title>. <source xml:lang="en"/>PLoS Biol
<volume>13</volume>: <fpage>e1002217</fpage>
<pub-id pub-id-type="pmid">26252244</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0121">
<mixed-citation id="embj2019104163-cit-0121" publication-type="book">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>K</given-names>
</string-name> (<year>2017</year>) <chapter-title>COUP ‐ TF genes, human diseases, and the development of the central nervous system in murine models</chapter-title>
<source xml:lang="en"/>Current topics in developmental biology
<publisher-name>Elsevier</publisher-name>
<fpage>275</fpage>–<lpage>301</lpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0122">
<mixed-citation id="embj2019104163-cit-0122" publication-type="journal">
<string-name>
<surname>Zembrzycki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Griesel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Stoykova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mansouri</surname>
<given-names>A</given-names>
</string-name> (<year>2007</year>) <article-title>Genetic interplay between the transcription factors Sp8 and Emx2 in the patterning of the forebrain</article-title>. <source xml:lang="en"/>Neural Develop
<volume>2</volume>: <fpage>8</fpage>
</mixed-citation>
</ref>
<ref id="embj2019104163-bib-0123">
<mixed-citation id="embj2019104163-cit-0123" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name> (<year>2013</year>) <article-title>Development of the fetal cerebral cortex in the second trimester: assessment with 7T postmortem MR imaging</article-title>. <source xml:lang="en"/>Am J Neuroradiol
<volume>34</volume>: <fpage>1462</fpage>–<lpage>1467</lpage>
<pub-id pub-id-type="pmid">23413246</pub-id></mixed-citation>
</ref>
<ref id="embj2019104163-bib-0124">
<mixed-citation id="embj2019104163-cit-0124" publication-type="journal">
<string-name>
<surname>Zhou</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>MJ</given-names>
</string-name> (<year>2001</year>) <article-title>COUP‐TFI: an intrinsic factor for early regionalization of the neocortex</article-title>. <source xml:lang="en"/>Genes Dev
<volume>15</volume>: <fpage>2054</fpage>–<lpage>2059</lpage>
<pub-id pub-id-type="pmid">11511537</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>